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Abstract 
The specific labeling of proteins with synthetic probes is a powerful approach to study 
protein function and protein tags have been widely used for this purpose. A well-
established example for a self-labeling protein tag is SNAP-tag. It specifically reacts 
with a wide variety of O6-benzylguanine derivatives (BG-derivatives) and was 
derived from the human O6-alkylguanine-DNA alkyltransferase (hAGT) by protein 
engineering. Relative to hAGT, SNAP-tag possesses a 52-fold higher reactivity 
towards BG-derivatives, does not bind to DNA and expresses well in cells as on cell 
surfaces. It is known that alkylation of hAGT results in protein unfolding and 
degradation. However, an increased degradation of SNAP-tag fusion proteins after 
labeling has not been observed.  
The first part of this work focused on the structural basis underlying the differences in 
protein stability between SNAP-tag and hAGT. A detailed biochemical and structural 
analysis was performed to determine (i) the interaction of SNAP-tag with its 
substrate, (ii) the factors responsible for its increased reactivity and (iii) how the 
labeling affected the stability of the protein. Besides an increased reactivity with BG-
derivatives the superior stability of SNAP-tag compared to the parent protein hAGT 
could be confirmed. Whereas wild-type hAGT was rapidly degraded in cells after 
alkyl transfer, benzylated SNAP-tag showed a higher stability against proteolytic 
degradation. Moreover, the combination of our crystallographic and computational 
data provided further insight into the structural basis for the improved properties. The 
data indicated that the intrinsic stability of a key alpha helix was an important factor 
in triggering the unfolding and degradation of wild-type hAGT and provided new 
insights into the structure-function relationship of this DNA repair protein.  
	   ii	  
The second part was aiming for the generation of a new SNAP-tag-based inhibitor 
complex. It was envisaged that this complex would interact with the target protein via 
amino acid loops and decrease its function only upon labeling with BG-inhibitor 
molecules. Therefore, SNAP-tag was modified by the insertion of stretches of 
randomized amino acids and the generated protein libraries were screened for binding 
affinity. The utilization of two yeast-based systems, the yeast three-hybrid and two 
hybrid technologies, allowed for the differentiation of small-molecule dependent and 
independent binding interactions. It could be demonstrated that a specific protein-loop 
interaction can be generated by this approach. It could further be shown that 
inhibition of the catalytic activity of the target protein E.coli dihydrofolate reductase 
by a SNAP-loop mutant was possible.  
In summary this work revealed new insights into the stability of hAGT and SNAP-tag 
and the structure-function relationship of AGTs in general. Further, SNAP-tag 
engineering generated a new protein-binder whose affinity towards the target protein 
was leading to protein inhibition.  
 
Keywords: human O6-alkylguanine-DNA alkyltransferase, protein stability, reactivity, 
self-labeling protein tag, O6-benzylguanine, SNAP-tag, structure-function 
relationship, protein-protein interaction, yeast two-hybrid, yeast three-hybrid, 
dihydrofolate reductase, human polo-like kinase 4. 	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Zusammenfassung 
Um die Funktionsweise von Proteinen genauer zu untersuchen ist das spezifische 
Markieren von Proteinen mit synthetischen Molekülen ein viel verwendeter Ansatz. 
Kleine Proteine, sogenannte Protein-Tags, kommen für diesen Zweck häufig zur 
Anwendung. Ein bekanntes Beispiel eines solchen selbst markierenden Protein-Tags 
ist SNAP-tag. Dieser wurde von der humanen O6-Alkylguanin-DNA-Alkyltransferase 
(hAGT) durch Protein Engineering entwickelt und reagiert spezifisch mit Derivaten 
von O6-Benzylguanin (BG-Derivate). Verglichen mit hAGT reagiert SNAP-tag 52-
mal schneller mit BG-Derivaten, bindet nicht an DNA und lässt sich gut in Zellen als 
auch auf der Zelloberfläche exprimieren. Es ist bekannt, dass das Alkylieren von 
hAGT die Proteinstabilität beeinflusst und es dadurch zum intrazellulären Abbau des 
Proteins kommt. Für SNAP-tag und an SNAP-tag fusioniere Proteine wurde ein 
solcher Abbau allerdings nicht beobachtet.  
Der erste Teil dieser Arbeit konzentrierte sich daher auf die strukturellen 
Unterschiede zwischen hAGT und SNAP-tag. Es wurde eine detaillierte 
biochemische und strukturelle Analyse durchgeführt um folgende Aspekte genauer zu 
betrachten; (i) die Interaktion von SNAP-tag mit seinem Substrat BG, (ii) die 
Faktoren, die für die gesteigerte Reaktivität von SNAP-tag verantwortlich sind und 
(iii) der Einfluss der Alkylierung auf die Proteinstabilität. Durch diese 
Untersuchungen konnte neben der gesteigerten Reaktivität mit BG-Derivativen auch 
die höhere Stabilität von SNAP-tag bestätigt werden. Der Wildtyp hAGT wurde in 
unseren Experimenten nach der Alkylierung schnell abgebaut, wohingegen SNAP-tag 
eine höhere Stabilität gegen den Proteinabbau aufwies. Die Kombination unserer 
kristallographischen und computergestützen Daten führte zu weiteren Erkenntnissen 
bezüglich der verbesserten Eigenschaften. Unsere Daten zeigten, dass die intrinsische 
Stabilität einer alpha-helikalen Region eine wichtige Rolle für den Proteinabbau von 
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hAGT spielt und führten zu neuen Schlussfolgerungen über die Zusammenhänge von 
Struktur und Funktion in diesem Protein. 
Das Ziel des zweiten Teils war es ein neuartigen, auf SNAP-tag basierenden 
Inhibitorkomplex herzustellen. Dieser Komplex sollte an ein Zielprotein durch neu 
eingeführte Protein-Loops binden und nur nach der Reaktion mit einem BG-
Inhibitormolekül die Funktion des Zielproteins inhibieren. Dazu wurden 
randomisierte Peptidsequenzen in SNAP-tag eingeführt und die so hergestellten 
Proteinbibliotheken bezüglich ihrer Bindungsaffinität selektiert.  Die Verwendung 
von zwei auf Hefe beruhenden Selektionssystemen, die Yeast Two-Hybrid und Three-
Hybrid Systeme, erlaubten die Unterscheidung von BG-Inhibitor abhängigen und  
-unabhängigen Interaktionen. Mit diesen Ansätzen war es möglich eine spezifische 
Interaktion zu generieren und es konnte gezeigt werden, dass eine Mutante von 
SNAP-tag die Eigenschaft besitzen kann die katalytische Aktivität des Zielproteins 
E.coli Dihydrofolatreduktase zu inhibieren. 
Zusammenfassend konnten in dieser Arbeit neue Erkenntnisse bezüglich der 
Proteinstabilität von hAGT und SNAP-tag gewonnen werden und Rückschlüsse 
bezüglich der Beziehung von Struktur und Funktion für Alkyltransferasen im 
Allgemeinen gezogen werden. Es konnte darüber hinaus gezeigt werden, dass durch 
SNAP-Tag Engineering ein neuartiger Protein-Binder generiert werden konnte, 
welcher die Aktivität des Zielproteins inhibierte. 
 
Schlüsselwörter: humane O6-Alkylguanie-DNA Alkyltransferase, Proteinstabilität, 
Reaktivität, Selbstmarkierender Protein-Tag, O6-Benzylguanin, SNAP-Tag, Struktur-
Funktionsbeziehung, Protein-Proteininteraktion, Yeast Two-Hybid, Yeast Three-
Hybrid, Dihydrofolatreductase, Polo-like Kinase 4. 
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 Introduction 
 1 
1 Introduction 
1.1 Engineering for the directed evolution of proteins 
 
Directed evolution mimics natural evolution as random mutagenesis is applied to a 
protein and improved variants with the desired qualities are picked out by diverse 
selection strategies. Tailoring the catalytic activity or stability of a protein has become 
a subject of interest among bioengineers as the application of proteins in the medical 
or industrial field has strongly increased over the last decade1-3. The results of these 
experiments also advanced our understanding of the forces that shape protein 
evolution and gave us a detailed knowledge about the structural aspects that are 
important for protein function4. 
The set-up of experiments may vary widely, however all directed evolution 
experiments share the same basic evolutionary principles (Figure 1). The starting 
point is the parent protein and the engineering goal, for example the increase in 
protein reactivity. The gene of the parent protein is then modified, either by error-
prone PCR5-7, DNA shuffling8-13 or saturation mutagenesis14-16. In that way a library 
of different proteins is produced and subsequently screened for the desired function, 
mostly upon expression from an adequate expression system (bacteria, yeast or 
mammalian cells). Improved proteins are separated, amplified and may be 
resubmitted to further rounds of protein evolution, until the protein exhibits a 
sufficiently high level of the desired property. 
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Figure 1: General scheme of directed evolution. The parent gene of a protein of interest serves as starting point. 
The first step is the modification by random mutagenesis and/or gene recombination (1). Depending on the 
screening system of choice this gene pool library is expressed in a host system (2). The screening/selection step 
enriches the positive colonies that carry improved versions of the protein of choice (3). Most often several iterative 
rounds of gene randomization are needed until a satisfying degree of optimization has been achieved (4). The 
improved proteins are isolated and expressed in bigger quantity to further analyze their new properties in 
additional experiments. Illustration taken and modified from Johannes et al. 3.  
Saturation mutagenesis was found to be advantageous in exploring non-conservative 
amino acid substitutions in protein engineering. Random point mutagenesis on the 
protease subtilisin S41 identified Lys211 and Arg212 as a pair of residues that could 
improve protein stability16. Saturation mutagenesis of these residues selected highly 
hydrophobic residues for these positions and a significant number of mutants 
surpassed the stability of the point mutants. The selected amino acids were only 
accessible by multiple (two to three) base substitutions in a single codon and would 
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have been extremely rare in a point mutation library or in natural evolution. This 
study illustrated the power of laboratory protein evolution and emphasized the 
potential of saturation mutagenesis for the improvement of target proteins as a 
pathway that has been rarely explored in nature, but might offer important 
improvements as an alternative group of amino acids is made available16. 
 
1.2 Protein-tags and the evolution of SNAP-tag from human 
O6-alkylguanine DNA-alkyltransferase 
The possibility to select for certain protein features enabled the development of 
protein-tags. Protein tags are peptide sequences that are attached to proteins for 
various purposes. Amongst them, auto-fluorescent proteins represent an important 
group of protein-tags. They have been widely used for studying various aspects of 
protein function, from intracellular localization to rates of protein turnover17. Even 
though important advancements have been made in the field of auto-fluorescent 
proteins18-21, alternative protein-based tags that can be modified with a large variety of 
small molecule-derivatives remain an important alternative for the study of both 
extra- and intracellular proteins22,23. 
An example for a fluorescent protein tag of very small size is the FlAsH-tag 
(Fluorescein Arsenical Helix binder). A tetrahistidine-tag can be labeled with 
biarsenical fluorophores to visualize intracellular proteins and the formation of 
biological complexes in living cells24,25. However, its main disadvantage is the 
unspecific binding as the probe can cross-react with thiols present in other proteins 
and cofactors such as lipoic acid26 which is leading to high background signals.  
Besides these two tag-systems, several protein-based labeling-techniques have been 
developed that offer a broader variety in the labeling with small molecules22. Those 
can be broadly divided into two categories:  (i) enzyme-mediated tag labeling that 
requires the presence of a recognition sequence in the target protein and co-expression 
of an enzyme to perform the labeling reaction and (ii) self-labeling proteins that can 
transfer the functional part of a small molecule probe to the active site residue without 
any need of cofactors. The main advantage of the first approach is the small tag size 
Introduction   
 4 
and the high specificity of an enzyme catalyzed reaction. However, it is often 
restricted to the labeling of cell surface proteins as the enzyme expression inside the 
cell might interfere with intracellular processes27,28.  
In contrast, self-labeling proteins offer the advantage to function without any special 
co-factors and can generally be used for intracellular applications and in vivo 
experiments. The first developed self-labeling tag was the SNAP-tag29, which will be 
discussed in more detail. Other well-known examples of self-labeling protein tags 
include the orthogonal mutant CLIP-tag30 and HaloTag31.  
The labeling mechanism of SNAP-tag is based on the covalent transfer of a 
functionalized benzyl group of an O6-benzylguanine derivative to an active site 
cysteine to form a covalently modified protein29,32,33(Figure 2). The development of 
this protein-tag permits the labeling of SNAP-tag fusion proteins with a wide variety 
of different synthetic probes22.  
 
 
Figure 2: SNAP-tag reaction scheme with O6-benzylguanine derivative. The reactive cysteine 145 of SNAP-tag 
reacts with the benzyl moiety of the compound. After the reaction SNAP-tag is covalently labeled with the 
derivatized benzyl-part. SNAP-tag expression as fusion to a protein of interest enables the covalent labeling with a 
broad variety of compounds for cellular experiments.  
SNAP-tag was generated in a stepwise manner from human O6-alkylguanine-DNA 
alkyltransferase (hAGT) by introducing a total of 19 point mutations and deletion of 
25 C-terminal residues. During directed evolution of the protein an emphasis was put 
on the increase of reactivity towards O6-benzylguanine-derivatives (BG-derivatives). 
Additionally, non-essential cysteines were removed and further mutations were 
introduced to abolish DNA-binding26,34,35. The next paragraph focuses on the wild-
type protein hAGT, its role in nature and reveals important aspects on hAGT stability.  
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1.2.1 The human O6-alkylguanine DNA-alkyltransferase (hAGT). 
The wild-type protein hAGT belongs to the group of DNA-repair proteins, which 
remove alkyl groups from the O6-position of guanine and the O4-position of thymine 
residues in DNA (Figure 3A). Alkylation at these positions represents an  
endogeneous damage of DNA and leads to G:C to A:T transition in DNA base-paring. 
In chemotherapies that are based on alkylating agents such as bischlorethylnitrosourea 
(BCNU), hAGT plays a significant role in the development of resistance36. O6-
benzylguanine is one of the best-known inhibitors of alkyltransferase and has been 
used as a very potent enhancer for chemotherapeutic agents37(Figure 3B). As for 
SNAP-tag, that follows the same reaction mechanism than hAGT, the alkyl-, or 
benzyl transfer leads to a covalent bond formation and is irreversible. As hAGT is a 
single turnover protein, nature developed an efficient way of hAGT removal after 
alkylation. Several studies have shown that alkylated hAGT is degraded very rapidly 
by the ubiquitin-proteasome pathway38,39.  This is grounded in the fact that the 
alkylation event triggers a conformational change, which renders the protein more 
sensitive to proteolysis by proteases40,41.  
 
Figure 3: hAGT reaction mechanism (A) on O6-methylated guanine bases and (B) with the potent 
alkyltransferases inhibitor O6-benzylguanine. Both alkylation reactions induce structural changes in hAGT leading 
to protein unfolding and increased ubiquitination and degradation via the proteasome pathway. 
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1.2.2 Protein stability 
Understanding the factors that control protein stability and therefore the ability of the 
protein to function under harsh conditions e.g. high temperature or organic solvents, is 
of scientific and commercial interest1. 
Proteases and peroxidases were amongst the first enzymes to be evolved for increased 
stability, mainly because of the need for stable and functional variants for detergent 
and laundry application42-44.  
A general method to design the stability of a protein through protein engineering was 
developed by Schmid and coworkers45. In the reported approach named Protein 
Stability Increased by Directed Evolution (ProSIDE), filamentous phage is used to 
assess the stability of a protein library by determination of the proteolytic 
susceptibility1,46. A similar approach was published earlier by Kristensen et al.47 The 
protein sequence to be evolved is sandwiched between two domains of the g3p 
protein, which is important for phage infectivity. Phages carrying clones that due to 
the inserted mutants do not fold properly are not able to propagate and are therefore 
eliminated from the screen. The propagated phages are further selected for high 
stability mutants by applying a selection pressure (either high temperature or 
guanidinium hydrochloride salt) followed by a protease treatment, which destroys 
phages with non-correctly folded proteins. This screening method assumes a direct 
correlation between proteolytic resistance and increased stability but it could be 
shown by other groups that this correlation cannot always be applied48,49. 
Besides phage-based screenings the use of thermophilic microorganisms and selection 
by auxotrophic markers turned out to be a powerful approach to improve protein 
stability50. 
Despite a large number of studies on the stabilization of protein-folds by rational or 
random approaches the proposition on strict design rules that would be applicable to 
new targets is difficult1,51. It rather became clear, that there are many structural ways 
that can be employed to increase stability52. However, some general conclusions can 
be drawn from the studies on protein stability. First, enzymes that were evolved for 
stability mostly carry mutations located on the surface of the protein, rather than in 
secondary structural elements. This might be due to a higher tolerance for structural 
changes as surface residues are rarely decisive for the protein fold, neither directly 
involved in catalytic activity1. Moreover, it has been suggested that high stability is 
dependent on rigidity53. This is unfavorable for enzyme activity and could explain the 
 Introduction 
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fact why the same proteins, one derived from a thermophilic organism, the other from 
a mesophilic source, have the tendency to be similarly active at their respective 
optimal temperatures. In the thermophile protein the beneficial effect of temperature 
on the catalytic rates is counterbalanced by the increased rigidity54,55. This principle is 
less true for proteins that were evolved in the laboratory, as selection pressure for 
improvements in catalytic activity can be uphold while improving protein stability as 
well56.  
 
1.3 The importance of protein-protein interactions 
An important field for protein engineering is the design of novel protein binders. 
These proteins have become increasingly important over the last years for research, 
diagnostic- and therapeutic applications. Here, the importance of protein-protein 
interactions in general will be discussed. Further, an overview of antibody 
engineering and the development of alternative scaffolds will be given. 
 
Proteins are essential for the function of an organism and participate in virtually every 
process within a cell. They mediate complex networks of interactions in all processes 
of life and molecular recognition by proteins ensures the specific interaction with 
other bio-molecules. An important example of interactions occurs during DNA 
replication, where large molecular machines are built through protein-protein 
interactions that carry out this important molecular process.  
In general, protein-protein interactions can be classified in stable interactions, and 
transient interactions. Stable protein interactions occur when the proteins are part of 
big macromolecular machines. Transient interactions are generally less conserved but 
of highest importance for a cell, e.g. as part of a signal transduction network57.  
Examples for a stable protein interactions are ATP synthase or protein transporters, 
such as the 50 MDa nuclear pore complex that selectively ensures the transport of 
cargo across the nuclear envelope58. These complexes have long lasting protein-
protein interactions to build up the functional structures and usually dissociate only 
when degraded by the proteasome. On the other hand, transient interactions as in the 
membrane-associated heterotrimeric G proteins can shift their equilibrium between 
oligomeric and monomeric state by a molecular trigger. Upon guanosine-
Introduction   
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triphosphate/-diphosphate exchange (GTP/GDP exchange) the affinity between the 
subunits Gα and Gβγ of the G-protein complex changes about 1000-fold, which 
permits the complex to function as regulatory switch for the effective control of 
dynamic protein networks59.  
All the above-mentioned examples show the importance of proteins and their role in 
living organisms. The wealth of proteins and the numerous possibilities for 
modification makes them very sensitive regulatory elements essential for the specific 
network signaling in living systems. This is why the elucidation of protein interaction-
networks has become an important field of research60 and large-scale determination of 
proteome-wide protein interactions using two-hybrid analysis has allowed great 
progress in understanding biological systems61-66. Interaction maps derived from these 
studies serve as unique resource for further analysis and use in the medical field. Over 
many years this knowledge has been useful for medical applications for the targeted 
disruption of intracellular signaling pathways by chemotherapeutic treatments using 
chemical small-molecules. More recently, the research on protein-protein interactions 
has led to the development of protein-based drugs, the so-called “biologics” and more 
and more of these new drugs are entering clinical trials. Protein scaffolds based on 
immunoglobulins were amongst the most successful ones, proven by the more than 20 
different drugs that have been approved so far67. In parallel, important advances in the 
field of combinatorial protein design led to the development of a new generation of 
affinity proteins that are no longer based on the immunoglobulin scaffold68. These 
alternative proteins possess many advantages over classical antibodies and have and 
impressive therapeutic potential69.  
 
 
1.4 Antibodies: 
Antibodies are one of the most important protein classes of the immune system, 
essential for the identification and neutralization of foreign objects as bacteria or 
viruses. They recognize specifically a unique part of their target protein, the antigen, 
and bind to it with very high affinity. This remarkable capability is grounded in the 
architecture of antibodies, more precisely in the arrangement of polypeptide chains in 
the antigen-binding fragment (Fab)70. The antigen binding-site situated at the N-
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terminal end of the Fab-fragment contains the so-called Complementary Determining 
Regions (CDRs). These are flexible peptide loops interconnecting the intertwined 
beta-sheets that make up the antigen binding-site. These loops are exposed on the 
surface and have the capability to complement the antigen’s shape, which determines 
the protein affinity and specificity. Due to somatic recombination, antibodies show 
extremely high variability of their amino acid sequence, especially in the CDRs. The 
large pool of possible amino acid combinations ensures that antibodies can be raised 
against virtually any possible antigen. Besides their important role in protecting host 
organisms against infections, antibodies turned out to be extremely useful for 
therapeutic applications and in biotechnology. Especially the development of 
techniques to produce monoclonal antibodies that can uniformly recognize one 
specific site on a target-protein increased the application of antibodies in medical 
therapy and biochemistry71,72. Typical fields of indications are rheumatoid arthritis, 
multiple sclerosis and different types of cancer but taking into account the recent 
development in antibody engineering many more indications are to come in the 
future73,74.  
 
 
1.5 Alternative scaffolds:  
The emergence of bioengineering techniques to screen large protein libraries 
accelerated the engineering efforts on diverse protein scaffolds different from 
antibodies. They have been successfully used to design very potent protein binders 
and are used as investigational tools, for diagnostics and therapeutic applications67,75-
77(Figure 4).  
As shown in elegant work by Plückthun et al. the use of an engineered form of 
ankrin-repeat motives yields very selective, high-affinity protein binders against 
diverse targets78,79. Designed Ankrin-Repeat Proteins (DARPins) bind very 
specifically to the human epidermal growth factor receptor 2 (Her2). This receptor is 
an important target for cancer therapy and diagnosis and DARPins against Her2 have 
been used to determine the status of Her2 over-expression in different carcinomas and 
may also have a potential use in targeted therapy. Additionally, alternative protein 
scaffolds were developed. The most popular ones are monobodies80, Kunitz 
Introduction   
 10 
domains81 and anticalins82. Even though monobodies were derived from fibronectins 
and not immunoglobolins, their structure is based on a ß-sandwich and thus shows a 
similar binding mode to that of antibodies80. Anticalins are not homologous to the 
immunoglobulin superfamily. Besides the selective binding to protein structures they 
can recognize molecules of lower molecular weight, as toxins or dioxigenin83,84. The 
discovery of a high structural plasticity in certain parts of the protein and an induced-
fit upon target binding were two features so far being considered as typical for the 
binding sites of antibodies but were also found in anticalin scaffolds67. Kunitz 
domains are composed of a disulfide rich alpha-/beta-fold and have a size of about 6 
kDa. Due to their long peptide loop gathering at the tip of this wedge-shaped proteins, 
Kunitz domains tend to bind targets with concave surfaces such as clefts for enzyme 
substrates or pockets for natural ligands85,86.  
 
 
Figure 4: Application possibilities for non-immunoglobulin scaffolds that were engineered for specific protein 
binding by diverse protein-engineering approaches. Figure taken from Grönwall et al. 87. 
These examples show how engineered proteins derived from different protein 
scaffolds have become valuable tools for medical applications, diagnosis, molecular 
biology research and biotechnology. The creation of new target-specific binding 
SCAFFOLD
PROTEIN
Functional
inhibition
Structure
determination
Gene delivery
In vivo imaging
Biotherapeutics
Diagnostics
Detection
Purification
Depletion
B
io
te
ch
no
lo
gy
Biological research
Medicin
e
 Introduction 
 11 
proteins through the creation of novel protein libraries and the application of diverse 
screening techniques has been very successful in the past. With the development of 
even more sensitive systems and the help of structural data coming from 
crystallographic and computational efforts, their range of application will continue to 
grow67. An overview of the most prominent screening techniques will be given in the 
next paragraph.  
?
1.6 Overview of selection systems used to identify new affinity proteins: 
Despite our knowledge about proteins the rational design of new proteins is still a 
difficult task. The in silico prediction of the effects of various mutations is 
challenging and experimental re-optimization is needed in most cases51. To identify 
protein variants with improved functions, the screening of protein libraries has been 
the most promising approach over decades. Improvements in protein stability, 
reactivity or substrate specificity, as well as the isolation of proteins with novel 
binding specificities have been achieved by these selection systems. All methods 
share the common principle to link the phenotype of the protein with its genotype. As 
sequencing of proteins is still difficult this principle enables easy identification and 
amplification of the selected polypeptides via the nucleic acids. All selection systems 
follow the principle of diversification, selection and amplification: After the creation 
of a protein library the proteins that show the new property are selected, amplified and 
tested. It is possible that several rounds of diversification, selection and amplification 
are done prior to characterization in order to enrich for the right proteins. The 
different selection systems described below focus on the selection of new affinity 
proteins and can be divided in three categories; cell-dependent display systems, cell-
free display systems and non-display systems.  
 
1.6.1 Cell-dependent systems:  
In cell-dependent systems as phage-display88, the library proteins are displayed on the 
surface of cells or in a cellular compartment. It is possible to select positive clones 
with powerful flow cytometric techniques without any need for elution from the target 
protein. Major disadvantages are the limitation of library size due to the 
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transformation efficiencies of DNA and the need for the target protein to be available 
in large quantities, preferably in its native form.  
Phage display. 
Phage display uses bacteriophages to connect the proteins with the encoding genetic 
information. Most commonly filamentous phages are used87. For the display of 
foreign proteins on the surface of phage the gene encoding the protein of interest is 
fused to the phage gene of one of the major coat proteins pVIII or pIII. pVIII is 
produced in 2700 copies and covers the whole phage particle and only short peptides 
are tolerated in selection89. pIII is only present in five copies at the tip of the phage 
and can be used for the fusion of larger proteins, as antibodies. During virus assembly 
the produced fusion proteins are incorporated into the phage particle enabling the 
protein display on the phage surface and the selection for affinity binders against the 
protein of interest90. Assembly of phage particles displaying the protein library is 
done by infection of E.coli cells carrying the DNA information of the library with 
helper phage. After incubation of phage particles with the target protein interacting 
phage is captured and unbound phage washed away. After elution the phage is used to 
infect new E.coli cells to amplify selected clones. This panning process is typically 
repeated between three- to four times to insure a good enrichment of high affinity 
binders.  
The technology was originally discovered in 1985 by Smith et al.91 He demonstrated 
that selection for peptides that were genetically fused to the gene of pIII of 
filamentous phage was possible, if an antibody against these peptides was available. 
Since then, this technology has been further developed and improved and was 
successfully used, i.a. antibody engineering92-98. The method has equally been used 
for display of libraries of alternative non-immunoglobulin protein scaffolds78,99-101 and 
for drug discovery102-104. 
 
 
Yeast display.  
Yeast display has been one of the first alternatives to phage display, first reported by 
Boder and Wittrup105, its major advantage being the possibility of mammalian protein 
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expression in a eukaryotic host system. Similar to phage display, proteins or peptides 
are displayed on the yeast surface. Therefore, the proteins are displayed as fusion 
proteins with the Aga2p subunit, a protein needed for the yeast to mediate cell-cell 
contacts during the mating process. Aga2p attaches to the yeast cell wall by 
interaction with the Aga1p protein. For yeast display, both proteins are under the 
control of inducible promoters. After induction, approximately 104 to 105 copies of 
the recombinant proteins are displayed per yeast cell105,106. A big advantage of yeast 
display over other selection techniques is the possibility to use Fluorescence-
Activated Cell Sorting (FACS) for the isolation of antigen-binding cells. For this, 
fluorescent-labeled target is added to the cell-displayed protein library prior to FACS 
screening. This method allows the monitoring and quantification of the relative 
affinities for the target of each library member already during the selection process. 
The introduction of two protein-tags, an N-terminal HA-tag and a C-terminal c-myc-
tag in fusion to the displayed proteins, allows for the quantification of full-length 
expression efficiency and the amount of displayed protein on the yeast surface107.  
Due to a lower transformation efficiency in yeast compared to E.coli the construction 
of large naïve libraries can be more difficult. Differences in the glycosylation pattern 
of yeast-expressed proteins compared to mammalian cells can be disadvantagous 
when using this technology, but it has not limited the success of the approach for a 
number of applications. For instance, using this technology, Buonpane et al. 
succeeded in the isolation of a femtomolar affinity binder108,109. It has also been 
shown that the combination of directed evolution and yeast display could improve the 
affinity of an integrin α-subunit to the intracellular adhesion molecule 1 by 200,000-
fold110. 
 
Bacterial display.  
Similarly to yeast cells, bacteria can also be used for displaying proteins. Mostly used 
host system is a Gram-negative bacterium E.coli, its major advantages being the rapid 
growth rate, easy handling and the possibility of making large libraries of up to 1011 
different variants being screened111. The use of gram-positive bacteria as 
Staphylococcus carnosus have been reported112,113. Major limitation of this method is 
the presentation of correctly folded protein on the cell-surface. Problems can arise due 
to the choice of carrier protein, the amount of disulfide-bonds, as well as the size of 
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the displayed protein. For the facilitated display of larger, more complex molecules 
on E.coli a variation of the classical bacterial display called the Anchored Periplasmic 
Expression (APEx) has been developed114,115. For this, proteins are displayed on the 
periplasmic-side of the inner membrane. During the selection process, the membrane 
is disrupted or permeabilized and the fluorescent-labeled ligand can bind to the 
displayed protein. As for yeast display, sorting of positive clones via FACS analysis is 
the method of choice. Bacterial display was recently applied to the successful 
isolation of a high affinity affibody targeting TNF-α from a naïve affibody library 
previously enriched with one round of phage display116. The successful application of 
gram-positive bacteria S. carnosus for large-scale epitope mapping of antibodies 
through the display of antigen libraries on the surface of the cells and subsequent 
FACS analysis has been reported117,118.  
 
1.6.2 Cell-free systems:  
Large libraries with up to 1013 mutants can be screened using cell-free systems as 
ribosomal display or mRNA display. Library construction is based on in vitro 
transcription and translation, which also enables the possibility to introduce in vitro 
mutagenesis during amplification rounds.  
Ribosomal display. 
In order to circumvent restrictions in library size due to limitations in DNA 
transformation efficiencies, cell-free systems as the ribosomal display have been 
developed119,120. The crucial point in this system is the fusion of the library DNA to a 
spacer sequence lacking a stop codon. During in vitro translation this spacer sequence 
stays attached to the peptidyl tRNA and occupies the ribosomal tunnel. As this 
sequence is C-terminal to the amino acid sequence of the library protein it has already 
been translated that it protrudes out of the ribosome and folds. The resulting complex 
of protein, mRNA and ribosome can then be subjected to panning against the target 
protein. Low temperatures and high Mg2+ concentration can further stabilize the 
mRNA-ribosome-protein complex121. After elution of bound protein from the target, 
the mRNA can be reverse transcribed to cDNA and further analyzed. At this stage, an 
additional round of mutagenesis can be introduced to increase the selective pressure.   
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mRNA display. 
A higher stability of the mRNA-protein complex can be reached by mRNA display, 
where the mRNA is covalently linked to the polypeptide through the antibiotic 
puromycin122. The structure of puromycin resembles the 3’ end of an aminoacyl-
tRNA molecule and can readily enter the ribosomal A site and be incorporated into 
the nascent peptide. The mRNA-polypeptide fusion is then released from the 
ribosome.  
The possibility to use large libraries with up to 1015 different members is a strong 
advantage of the in vitro translation methods123. Non-natural amino acids can be used 
during translation and in vitro mutagenesis can be easily incorporated during the 
individual selection rounds to increase the genetic variability in the sequence pool. 
The covalent binding and the smaller size of the linker fragment puromycin are 
advantageous over mRNA-protein linkage via the ribosome as in ribosomal 
display124.  
 
1.6.3 Yeast two-hybrid: 
An alternative system for the direct evaluation of protein-protein interactions is the 
yeast two-hybrid (Y2H) screening that was first applied by Chien et al. in 1991125. 
The system is based on the modular organisation of transcription factors that when in 
close proximity trigger reporter gene transcription. The first protein to be used for this 
was the yeast protein GAL4. Nowadays, the DNA-binding domain of the E.coli 
protein LexA is used. GAL4 has a DNA-Binding Domain (BD) and an Activation 
Domain (AD). When GAL4 binds to its cognate binding site, the activation domain is 
brought close to the promoter, allowing the activation domain to interact with the 
transcription machine and gene transcription.  
The first basic experiment that opened the way to library screening was the discovery 
that the N-terminal fusion of the DNA repressor LexA from E.coli to the yeast 
activation-domain GAL4 could trigger protein transcription, but only when a LexA 
operator was present near the transcription starting site126.  
Further pioneering work was done by Fields et al. as they used GAL4 transcriptional 
activation for the detection of protein-protein interactions127. They showed that the 
reconstitution of proximity of the GAL4 BD and the GAL4 AD could be mediated via 
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the interaction of the proteins SNF1 and SNF4. The interaction of these two fusion 
proteins would lead to the activation of a reporter gene downstream of the GAL4 
binding site. The authors envisioned to replace one fusion protein by a genomic 
library of cDNA sequences fused to the GAL4 AD. A target protein could then be 
fused to the GAL4 BD. In case of protein interaction both GAL4 domains would be 
brought in close proximity and trigger reporter gene transcription. Cells expressing 
two interacting proteins would then be selected based on reporter gene transcription 
(auxotrophic marker or colorimetric assay). The first Y2H screening against Sir4-
binding proteins was published two years later125 in which the authors confirmed the 
known homodimerization of Sir4.  
Since then, Y2H screenings have become a highly used method for the detection of 
protein-protein interactions (Figure 5) and large-scale protein interaction mapping 
projects have been realized for several organisms (S.cerevisiae62,66, C. elegans63, 
Drosophila melanogaster61 and recently human65,128).  
 
Figure 5: Yeast two-hybrid detection principle. Bait-LexA DNA-binding domain fusion protein is co-expressed 
with prey-GAL4 activation domain fusion protein in yeast cells. In the case of bait-prey interaction, the 
transcription of a reporter gene (e.g. HIS3 reporter gene) is activated. The transcription product allows the yeast 
cell to survive on auxotrophic media and colonies of the interacting protein pair will be detected in a screening.  
A crucial point for these large-scale screening projects is the quality of the cDNA 
libraries. Historically, cDNA libraries have been produced by more or less random 
fragmentation of genomic DNA or random primed cDNAs were prepared from the 
mRNA of diverse tissues129. The disadvantage of libraries created in this way is the 
uncontrolled fashion in which the coding sequences of the inserts are attached to the 
coding sequence of the transcriptional activator. Some consequences of this approach 
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include the expression of the wrong reading-frame or from sequences of the 
untranslated regions of the mRNA. The resulting non-natural proteins provide a rich 
source for non-specific interactions that add to the number of false positives. 
Recently, more and more cDNA libraries comprising the full-length open reading 
frame (ORF) of the mRNA are generated for several species130-132, in part in dedicated 
efforts to provide new resources for Y2H screening133-135.   
A modification of the yeast two-hybrid screening is the yeast three-hybrid system that 
has been used successfully for the identification of small molecule-protein 
interactions. In this assay the two fusion proteins can only interact via a small 
molecule-anchor. Studies using methotrexate-DHFR136 or β-estradiol-biotin 
anchors137 to identify new protein-drug interactions have been published.  
Similar systems based on alternative reporter interactions have also been developed, 
as the split-ubiquitin assay that is based on the reconstitution of split-ubiquitin leading 
to the liberation or the reporter fragment in case of protein-protein interaction138 or 
small molecule-protein interaction139. The MAmmalian Small Molecule-Protein 
Interaction Trap (MASPIT)140,141 permits the detection of both modification-
independent and phosphorylation-dependent interactions in human cells. 
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1.7 AIMS OF THE PROJECT: 
 
Aim1: SNAP-tag is more reactive towards BG-derivatives and more stable than wild-
type hAGT. In this work, the structural differences between these two proteins were 
studied in more detail. Crystal structures of hAGT and SNAP-tag in their benzylated 
and non-benzylated state were the starting point from which further studies on the 
structure-function relationship were developed. The overall aim of this work was to 
obtain a detailed understanding of the impact of individual point mutations on SNAP-
tag stability and reactivity.  
 
Aim 2: The second part of this work was focused on protein engineering. The aim 
was to create a SNAP-tag-based inhibition complex, which interacts with a target 
protein through amino acid loops and decreases its function only upon labeling with 
BG-inhibitor molecules. Therefore, randomized amino acid loops were introduced at 
distinct positions of SNAP-tag and mutants were selected for small molecule 
dependent binding-affinity using Y3H-screening. Identified hits were tested for in 
vitro binding and target protein inhibition. 
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2 Directed evolution of hAGT to SNAP-tag – a study on 
the structure-function relationship 
In this chapter a biophysical, structural and computational analysis of the directed 
evolution of hAGT to SNAP-tag is presented. Relative to hAGT, SNAP-tag possesses 
a 52-fold higher reactivity towards BG derivatives, does not bind to DNA and 
expresses well in cells as on cell surfaces. However, we had a low understanding of 
how the introduced mutations affected protein activity and protein stability. We 
therefore performed a detailed study to understand the effect of the introduced 
mutations in terms of protein stability and reactivity. The results are presented in this 
chapter.  
2.1 Structural considerations 
SNAP-tag was generated in a stepwise manner from human O6-alkylguanine-DNA 
alkyltransferase (hAGT) by introducing a total of 19-point mutations (Figure 6) and 
deleting 25 C-terminal residues. Saturation mutagenesis of four active-site residues 
followed by phage display and selection for activity against BG derivatives resulted in  
GEAGT, a mutant with 20-fold increased activity towards such substrates (Figure 
6B)34. Subsequent saturation mutagenesis of four additional residues involved in 
substrate binding followed by phage selections resulted in AGT-54, a mutant with 
1.5-fold higher activity than GEAGT.  
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Figure 6: Overview of the directed evolution of hAGT to SNAP-tag: (A) Crystal structures of SNAP-tag C145A 
mutant co-crystallized with BG. Mutagenized parts of the protein are highlighted in color. (B) Relative reactivity 
of hAGT and mutants with BG-Cy3. (C) Sequence alignment of hAGT with intermediate mutants and SNAP-tag. 
Colors that highlight mutations correspond to those used in (A). 
hAGT MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA 50 
GEAGT MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA 50 
AGT54 MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA 50 
MAGT MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA 50 
SNAP MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IIFLGKGTSA ADAVEVPAPA 50 
  
hAGT AVLGGPEPLM QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW 100 
GEAGT AVLGGPEPLM QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW 100 
AGT54 AVLGGPEPLM QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW 100 
MAGT AVLGGPEPLM QATAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW 100 
SNAP AVLGGPEPLM QATAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW 100 
 
hAGT KLLKVVKFGE VISYQQLAAL AGNPKAARAV GGAMRGNPVP ILIPCHRVVC 150 
GEAGT KLLKVVKFGE VISYQQLAAL AGNPKAARAV GGAMRGNPVP ILIPCHRVVC 150 
AGT54 KLLKVVKFGE VISYQQLAAL AGNPKAARAV KTALSGNPVP ILIPCHRVVC 150 
MAGT KLLKVVKFGE VISYSHLAAL AGNPAATAAV KTALSGNPVP ILIPCHRVVN 150 
SNAP KLLKVVKFGE VISYSHLAAL AGNPAATAAV KTALSGNPVP ILIPCHRVVQ 150 
 
hAGT SSGAVGNYSG GLAVKEWLLA HEGHRLGKPGLG* 182 
GEAGT SSGAVGGYEG GLAVKEWLLA HEGHRLGKPGLG* 182 
AGT54 SSGAVGGYEG GLAVKEWLLA HEGHRLGKPGLG* 182 
MAGT INGAVGGYEG GLAVKEWLLA HEGHRLGKPGLG* 182 
SNAP GDLDVGGYEG GLAVKEWLLA HEGHRLGKPGLG* 182 
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To further optimize the protein for applications in protein labeling, mutations were 
introduced to suppress DNA binding and reactivity towards nucleosides, to remove 
non-essential cysteines and to truncate the last 25 residues35. The resulting mutant 
MAGT displayed relatively low activity towards BG derivatives (Figure 6B) (5-fold 
higher than hAGT). To rescue the activity of MAGT against BG derivatives, an 
additional round of saturation mutagenesis (residues 150-154 and 32-33) followed by 
phage display was performed, resulting in SNAP-tag142.  
 
A unique feature of O6-alkylguanine-DNA alkyltransferases is that the protein is not 
regenerated but degraded after DNA repair38. In mammalian cells, it is believed that 
alkyl transfer triggers a conformational change in hAGT, leading to ubiquitination and 
degradation of the alkylated protein38. Supporting this hypothesis is that alkylation of 
hAGT increases its sensitivity towards proteolysis in vitro40. Furthermore, structural 
analysis of hAGT before and after alkylation revealed that alkylation leads to 
sterically unfavorable interactions that result in partial unfolding of the protein143. 
Interestingly, an increased degradation of SNAP-tag fusion proteins after labeling has 
not been observed144.  
2.2 Studies on protein stability 
The directed evolution of hAGT to SNAP-tag was done in several evolutionary steps. 
The major selection criteria were changes in reaction speed. In order to understand the 
impact on protein reactivity and protein stability in more detail a structural study has 
been performed using experimental as well as computational methods to analyze the 
impact of the individual point mutations. All computational experiments have been 
done in cooperation with the laboratory of Prof. U. Rothlisberger, by E. Brunk and are 
presented here for further insight on the experimental results. 
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2.2.1 Proteolysis experiments:  
It has been previously reported that alkylation of wild-type hAGT increases the 
susceptibility of the protein towards proteases such as trypsin40. The increased 
protease susceptibility can be interpreted as a decreased stability of the alkylated 
protein. As a first measure of how the stability of hAGT changed in the course of its 
directed evolution into SNAP-tag, we therefore measured the susceptibility of the 
different hAGT mutants towards trypsin before and after labeling with BG-
fluorescein.  
 
 
Figure 7: Determination of protein stability by trypsin digestion. Strong differences were observed for hAGT, 
SNAP-tag and intermediate mutants. (A) SDS-PAGE of hAGT, GEAGT and SNAP-tag digestion mixes. (B) 
Fluorescence gel-scan used for quantification. (C) Quantification of fluorescence gel band intensities of all mutants 
at different trypsin concentrations. 
Proteins were titrated with increasing amounts of trypsin and analyzed on SDS-PAGE 
by coomassie staining (Figure 7, A) and by quantification of in-gel fluorescence 
(Figure 7, B). As reported previously, hAGT showed an increased susceptibility 
towards trypsin, especially upon labelling with BG-fluorescein. In constrast, no 
increased sensitivity of SNAP-tag could be observed. Furthermore, an almost 100-
fold higher trypsin concentration had to be used to degrade SNAP-tag to a similar 
extent as hAGT, indicating an increased stability of SNAP-tag. Mutations introduced 
in GEAGT (Asn157Gly, Ser159Glu) had a destabilizing effect, especially on the 
labeled protein. However, the trypsin resistance significantly increased for AGT-54 
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and MAGT. These data showed that during the directed evolution of hAGT for higher 
reactivity towards BG the stability of the protein, especially after benzylation 
increased drastically. It should be noted that the mutations introduced throughout the 
directed evolution of hAGT might not only affect the susceptibility towards trypsin by 
changing the stability of the protein but also via the introduction or removal of trypsin 
cleavage sites. We therefore sought to confirm these results through an independent 
assay.  
 
2.2.2 Thermal denaturation assay:  
In order to confirm independently the results obtained in the proteolysis experiment, 
we evaluated the stability of hAGT and mutants by thermal denaturation 145. The 
melting temperatures (TM) were determined with help of a fluorogenic molecule 
(SYPRO Orange®) that shows a strong increase in fluorescence upon binding to 
hydrophobic regions of a protein. Fluorescence intensity reached a maximum and then 
started to decrease, probably due to precipitation of the complex of the fluorescent 
probe and the denatured protein 146. We determined the melting temperatures of all 
proteins in the presence and absence of BG to assess the impact of benzylation on 
protein stability (Figure 8). We observed that the TM of SNAP-tag was increased by 
17 °C relative to hAGT. The directed evolution for higher reactivity towards BG 
derivatives led at the same time to an increased stability of the labeled protein relative 
to the unmodified protein (see ΔTM in Figure 8, A and B). A 10.2 °C decrease in 
melting temperature was observed for benzylated hAGT, whereas TM of SNAP-tag 
was reduced by only 3.5°C upon benzylation. These results were in agreement with 
the data obtained for the proteolysis experiments and could confirm the increased 
stability throughout protein evolution.  
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Figure 8: Melting point (TM) measurement for hAGT, SNAP-tag and mutants. (A) Raw data of thermofluor assay 
presented for hAGT and SNAP-tag before and after reaction with BG. Differences in ΔTM before and after 
benzylation are highlighted by arrows. (B) Melting point analysis. Shown are TM of pure protein (grey) and 
benzylated (light grey) as well as ΔTM before and after benzylation (dark grey). 
 
 
 
 
20 30 40 50 60 70 80 90
0
15000
30000
45000
60000
SNAP
SNAP + BG
hAGT
hAGT + BG
temperature (°C)
ΔTM, hAGT
ΔTM, SNAP
A
B
hAGT GEAGT AGT54 MAGT SNAP
30
40
50
60
70 pure
+BG
TM
0.0
2.5
5.0
7.5
10.0
12.5
15.0
 Results – Structural Studies on hAGT and SNAP-tag 
 25 
2.2.3 Stability of labeled hAGT and SNAP-tag in living cells: 
Our data on the sensitivity towards proteases and thermal denaturation showed a 
significantly increased stability of SNAP-tag relative to wild-type hAGT, in particular 
for the labeled protein. As hAGT is known to be rapidly degraded upon alkyl transfer 
in living cells 38 we investigated to what extend the increased in vitro stability of 
SNAP-tag would also translate into an increased intracellular half-life of the labeled 
protein. Therefore, we performed pulse-chase experiments with all mutants (Figure 
9). hgkhjhkjhjkhjkhjkhkjhkjhkjhkjhkjhkjhkjhkjhkjjkhkjhkjhkjhkjhkj 
 
Figure 9: Pulse-chase experiment of hAGT, SNAP-tag and mutants in HEK 293 cells. (A) Fluorescence gel scan 
of SDS-PAGE of hAGT and SNAP-tag pulse-chase experiments. Samples were analyzed at indicated time points 
for amount of fluorescence labeled protein present in each sample. (B) Plot of the relative fluorescence signal 
intensities for analyzed proteins as a function of time.  
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Suspension cultures of HEK 293 cells expressing the different mutants were 
incubated for 15 minutes with 0.65 μM CP-TMRstar (NEB) and the reaction was 
quenched with 100 μM of BG. Aliquots were taken at distinct time-points and 
analyzed on SDS-PAGE and by fluorescence gel scanning (Figure 9, A). Labeled 
hAGT showed a half-life of around 3 hours, whereas the apparent half-life of labeled 
SNAP-tag was determined to be approximately 42 hours (Figure 9, B). It should be 
noted that the actual half-life of SNAP-tag should be even higher, since the observed 
signal decrease results most likely from a dilution of labeled protein due to continuous 
cell growth. With respect to the intermediate mutants, labeled GEAGT showed similar 
stability as wild type hAGT (half-life of 2.7 hours), whereas AGT-54 showed an 
increased half-life of 11 hours and mutations introduced in MAGT resulted in a further 
prolonged the half-life of 16 hours (Figure 9, B). These data clearly show that labeled 
SNAP-tag is not degraded to a significant degree in living cells and that the directed 
evolution for higher reactivity resulted in the generation of mutants with increased in 
vitro stability that translates into an increased intracellular protein half-life.  
 
2.3 Structural analysis: 
In order to obtain further insights into how the mutations influenced the reactivity and 
stability of SNAP-tag, we obtained the crystal structures of (i) SNAP-tag, (ii) SNAP-
tag mutant Cys145Ala with BG bound and (iii) benzylated SNAP-tag. These 
structures were solved at 1.9 Å, 1.89 Å and 1.7 Å resolution, respectively (pdb entries 
3KZY, 3KZZ and 3LOO). The mutation C145A of the active site cysteine was 
necessary to prevent the reaction of protein with its substrate.  
Like hAGT, SNAP-tag consists of two domains and in all three SNAP-tag structures a 
Zn2+ ion was located in the N-terminal domain. As observed in the hAGT structure, a 
large flexible loop within the N-terminal domain of SNAP-tag was not resolved in the 
electron density maps (SNAP-tag: Lys36-Pro49, SNAP-tag benzylated: Gly35-Leu53, 
SNAP-BG: Gly35-Leu53). A comparison of the backbone structures of hAGT (PDB 
entry 1EH6) and SNAP-tag (PDB entry 3KZY) gave rise to a root mean square 
deviation (rmsd) of 0.794 Å calculated between Cα-positions for residues 1-182 of 
SNAP-tag and hAGT (EMBL-EBI, Secondary Structure Matching).  
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2.3.1 Substrate Binding: 
In all crystal structures, hAGT and SNAP-tag, Tyr114 and Val148 form hydrogen 
bonds to the purine and position the alkylated base for efficient alkyl transfer in the 
active site (Figure 10) 143. An overlay of SNAP-tag with SNAP-tag Cys145Ala co-
crystallized with BG shows that the thiol of Cys145 is in a 3.1 Å distance to the CH2 
of the benzyl ring and ideally positioned for alkyl transfer.  
In GEAGT mutations introduced at positions 157 and 159 (see red segment in Figure 
6A, C) increased significantly the reactivity towards BG. In particular, the 
introduction of Glu159 increased reactivity 20-fold (see GEAGT). We speculated 
previously that Glu159 would form a hydrogen bond with N7 of BG 34. Indeed, in the 
crystal structure of SNAP C145A with bound BG, one of the carboxylate oxygens of 
Glu159 is within 2.7 Å of N7 of BG. In addition, Cβ and Cγ of Glu159 make 
hydrophobic contacts with the benzyl ring of BG (distance approximately 3.7 Å), 
which is located between the glutamate side chain and Pro140 with an additional 
edge-on hydrophobic interaction with Tyr158. These interactions should facilitate 
substrate binding and stabilize the leaving group in the SN2 reaction. It is noteworthy 
that in the structure of SNAP-tag the side chain of Glu159 shows an alternative 
conformation that is not present in the structure of benzylated SNAP-tag, suggesting 
that binding of BG fixes the conformation of this residue. 
 
  
Figure 10: Active site of SNAP-tag C145A mutant (in grey) co-crystallized with BG; free SNAP-tag (in gold) is 
overlaid to highlight Cys145 positioning in reference to BG. Ala145, Gly157 and Glu159 (in bold) have been 
mutated compared to wild-type hAGT. Tyr114, Val148 and Glu159 form hydrogen bonds with the substrate. In the 
presence of BG Glu159 changes position and forms hydrogen bonding interaction with BG, Cβ and Cγ of Glu159 
make hydrophobic contacts with the benzyl ring of BG. Cys145 is in 3.1 Å distance to the CH2 of the benzyl ring 
and ideally positioned to perform the alkyl transfer. 
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2.3.2 Increased stability: 
It has been suggested that after alkyl transfer in hAGT, sterically unfavorable 
interactions between the benzylic CH2 group and the carbonyl oxygen of Met134 
cause a displacement of alpha helix 127-136 147. This displacement of the alpha helix 
triggers unfolding of the alkylated protein. In the structures of hAGT and benzylated 
hAGT, the displacement of helix 127-136 upon alkylation also manifests itself in an 
increased distance of the sulfur of Cys145 and Cys145benz to the carbonyl oxygen of 
Met134 from 4.2 to 4.6 Å (Figure 11B and D). In SNAP-tag, structural changes in the 
active site avoid unfavorable steric interactions upon benzylation (Figure 11 A and 
C). 
 
Figure 11: Distances between carbonyl oxygen of Met134 (in hAGT) or Leu134 (in SNAP-tag) and sulfur of 
Cys145 (A and B) or sulfur of benzylated Cys145 and CH2 of benzyl ring (C and D). In SNAP-tag distances upon 
benzylation remained virtually unchanged contrary to hAGT where the distance increases due to the movement of 
alpha helix 127-136 and the close proximity especially to the Met134 carbonyl group. 
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When overlaying the structures of SNAP-tag and benzylated SNAP-tag, a 
displacement of alpha helix 127-136 cannot be detected. Also, the distance between 
the sulfur atom of Cys145 and the carbonyl oxygen of Leu134 is 4.6 Å in SNAP-tag 
and this distance remains virtually unchanged upon benzylation (Figure 11 A and C). 
The absence of structural information on single point mutants makes an unambiguous 
identification of the key residues responsible for this structural change difficult, but 
we believe that particular mutations in the alpha helix 127-136 are important. 
Mutations introduced at this position of SNAP-tag shorten hydrogen bonds within the 
alpha helix considerably (Table 1): the distance between O131 and N135 is 3.0 Å in 
SNAP-tag but 3.8 Å in hAGT. Glycine residues are known to destabilize alpha helices 
if located in the middle of a helix 148,149 and the mutations in SNAP-tag result in a 
more compact alpha helix and increased available space in the active site.  
 
Table 1: Length of hydrogen bonding in alpha helix 126-137 for hAGT, benzylated hAGT, SNAP-tag and 
benzylated SNAP-tag. Mutations introduced in SNAP-tag lead to a shortening of the alpha helix hydrogen bonds, 
especially the distance of O131 – N135 changes a lot comparing hAGT with SNAP-tag.  
Especially Gly131 but also Gly132 are well conserved among O6-alkylguanine-DNA 
alkyltransferases 150 and it has been suggested that for steric reasons the flipping of 
alkylated bases out of double-stranded DNA requires glycines at these positions 
143,151. Our results suggest that Gly131 and Gly132 in hAGT also play an important 
role in triggering protein unfolding and degradation upon alkyl transfer. 
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The results of the decomposition show that the destabilization is 
mainly due to a loss of hydrogen-bonding interactions between the alpha helix 
(residues 127-136) and the loop (residues 157 and 159). While, overall, the mutation 
is destabilizing, the Ser159Glu mutation in GEAGT introduces a salt bridge interaction 
between Glu159 and Lys32 in the N-terminal beta sheet. Because of this interaction, 
Glu159 in our GEAGT model is oriented towards the beta sheet, as illustrated in Figure 
12B. It is noteworthy that this conformation would prevent hydrogen bonding of the 
glutamate carboxylate with BG. However, Lys32 is mutated to Ile during the directed 
evolution from MAGT to SNAP-tag. FEP/TI simulations of this transformation show 
that this mutation induces a destabilization in SNAP-tag (by a ΔG of 29 kcal mol-1).  
The per-residue decomposition of the ΔG indicates that the mutation Lys32Ile 
strongly affects Glu159, due to the loss of the salt bridge interaction (see Figure 12A 
and Figure 13 for more details on the per-residue decomposition). Further, the 
mutation  
 
Figure 13: Per-residue decomposition of the alchemical transformation of MAGT to SNAP-tag focussing on 
position 32-33. The effect on Glu159 is strong.  
Lys32Ile strongly affects the neighboring (charged) residues within the N-terminal 
beta sheet. Overall, the picture that emerges from our studies is that the mutation 
Ser159Glu in GEAGT increases the reactivity of SNAP-tag due to hydrogen bonding 
between Glu159 with BG. However, interactions with Lys32 keep Glu159 at least 
partially in an inactive conformation. The mutation Lys32Ile then increases the 
reactivity of SNAP-tag by disfavoring the inactive conformation of Glu159.  
Analogous studies of the transformation of residues 150 to 154 demonstrate that 
SNAP-tag is strongly stabilized over MAGT (a ΔG of 87 kcal mol-1), compensating 
the destabilizing effect of the mutation Lys32Ile, in agreement with the 
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experimentally determined melting temperatures. We performed a per-residue 
decomposition to evaluate the residues that are the highest contributors to the 
stabilization of SNAP-tag (Figure 14). 
 
Figure 14: Alchemical transformation of MAGT to SNAP-tag for residues 150-154. Mutations introduced in 
SNAP-tag contribute to the formation of a hydrogen bond network on the protein surface and clearly contribute to 
the gain in protein stability.  
We observed that the mutations Asn150Gln, Asn152Asp and Ala154Asp contribute 
the most to the free energy difference because they create a highly structured 
hydrogen-bonding network. The network extends from the alpha helix (Lys131 
hydrogen bonding to Gln150) to the tip of the loop (Gln150 hydrogen bonding to 
Asp154) to the C terminus (Asp152 hydrogen bonding to Arg175), as shown in 
Figure 15. The interactions within this hydrogen-bonding network are also observed 
during the MD trajectories and are preserved for 50 ns for both free and benzylated 
SNAP-tag structures.  
We could show that the evolution of hAGT to SNAP-tag led not only to increased 
protein activity but also to higher stability, especially of the alkylated protein. 
Whereas wild-type hAGT is rapidly degraded in cells after alkyl transfer, the high 
stability of benzylated SNAP-tag prevents proteolytic degradation. During the last 
rounds of protein evolution the selection for more reactive mutants yielded mutants 
with increasing stability. Mutations introduced in the recognition helix (residues 127-
136) and the adjacent loop-part (150-154) were major contributors to this 
improvement. 
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3 Engineering of SNAP-tag-based inhibitors of protein 
function 
3.1 Introduction:?
This chapter focuses on the development of a SNAP-based inhibitor of protein 
function. This inhibitor is a complex of two components, (i) a SNAP-mutant with 
binding affinity to the target protein and (ii) a small molecule inhibitor linked to BG 
(Figure 16). SNAP-mutant labeling with the BG-inhibitor molecule assembles the 
inhibitor complex, which binds to the target protein. The binding of the loop to the 
target protein surface leads to an increase in the effective concentration of the small 
molecule inhibitor at the active site of the target protein and to its inhibition.  
 
Figure 16: Assembley of the inhibitor complex. A loop-mutant of SNAP-tag reacts covalently with a BG-inhibitor 
derivative. The specific binding of the loop increases the effective concentration of the inhibitor molecule close to 
the active site of the target protein leading to an efficient inhibition of protein function. 
For the generation of a SNAP-mutant that specifically binds to the target protein, 
libraries of SNAP-tag mutants were constructed. SNAP-tag was modified by the 
insertion of a stretch of randomized amino acids at three different positions of the 
protein (see also Figure 19). The created protein libraries were screened for binding 
target
SNAP
mutant
?
linker
?
?
? ?
?
???
?
I
target SNAP
mutant
I
SNAP
mutant
I
+
BG-inhibitor molecule
SNAP-loop mutant
inhibitor complex inhibition of target protein
 Results – SNAP-based Inhibitor of Protein Function 
 
 35 
affinity towards two target proteins, E.coli dihydrofolate reductase (eDHFR) and 
human polo-like kinase 4 (Plk4).  
In order to identify affinity binders, a yeast two-hybrid (Y2H) and a yeast three-
hybrid (Y3H) approach were used, the latter based on a recently developed method in 
our laboratory152 (Figure 17). The loop mutant libraries were expressed as fusion 
proteins to the activation domain GAL4. The bait-proteins eDHFR and Plk4 were 
fused to the DNA-binding domain LexA. For Y2H screening the yeast cells were 
incubated on selection plates not containing any BG-molecule. SNAP-mutants having 
affinity to the bait protein trigger reporter gene transcription and induce cell growth 
(Figure 17, 1).  
 
Figure 17: SNAP loop-library screening approach with and without BG-inhibitor. In the classical Y2H screening 
(1) a loop-mutant with affinity towards the bait-protein can trigger reporter gene transcription. In parallel, a Y3H 
screen was performed (2). Therefore, a non-specific and rather low affinity small molecule inhibitior was 
derivatized with a benzylguanine-moiety. Reporter gene transcription depends on the binding of both parts, the 
loop-part, which ensures a specific binding to the bait-protein and the small molecule inhibitor-part, whose 
effective concentration at the active site of the bait protein would be strongly increased.  
Beside the detection of a direct bait and prey interaction, the Y3H screening was 
carried out including a BG-inhibitor molecule to detect small-molecule dependent 
interactions. Therefore, a non-specific and rather low affinity small molecule inhibitor 
was derivatized with a BG-moiety. In the ideal case, reporter gene transcription would 
be dependent on the binding of both parts, the loop-part which ensures a specific 
binding to the bait-protein and the small molecule inhibitor-part, whose effective 
concentration would be strongly increased upon loop-binding (Figure 17, 2).  
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Small-molecule dependency was tested by respotting of the yeast colonies on 
selective plates with and without BG-inhibitor molecule (Figure 18). Colonies that 
would grow on both plates express a mutant whose interaction does not depend on the 
small molecule inhibitor and would be considered as Y2H hits. If growth would 
depend on the BG-inhibitor molecule the cells should only grow on medium that 
contains the small molecule. This respotting step has been previously used for the 
identification of drug-targets from a genomic library where the dependency of yeast 
growth on the presence of the small molecule was successful for drug-target 
identification152. 
 
 
Figure 18: Determination of small-molecule dependency by colony respotting. Yeast colonies were respotted on 
fresh agar plates, only one supplemented with 10 μM of BG-inhibitor. In the case of a Y3H interaction, this should 
result in yeast growth only on the plate containing the BG-inhibitor but no growth should be observed in the 
absence of the molecule. Figure taken and adapted from C. Chidley et al.153 
 
3.2 Construction of SNAP-tag loop libraries 
This paragraph describes the construction of the SNAP-tag loop-libraries. In order to 
generate SNAP-tag mutants with binding affinity towards a target protein, SNAP-tag 
was elongated at 3 different positions (Figure 19). Besides the use of a C-terminal 
SNAP-tag library that was elongated by a stretch of six random amino acids at the end 
of the protein the introduction of loop-structures was envisioned. Earlier work of our 
group154 had shown that MAGT could be successfully modified by loop insertion at 
position 32/33 and 159/160 and a high quantity of correctly folded protein was 
obtained. We therefore decided to conserve these positions for SNAP-tag 
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modification and inserted a stretch of seven randomized amino acids including 
Glu159 and Gly160 for library 1 and eight randomized amino acids between Ile32 and 
Phe33 for library 2. The third library carried the C-terminal elongation of six random 
amino acids. 
 
Figure 19: Sites for loop-modification on SNAP-tag. Additional randomized amino acids were introduced at 
position 159/160 for library 1, at position 32/33 for library 2 and a C-terminal elongation for library 3. 
The randomized loop sequences were based on NNK codon usage (N for all four 
bases, K for thymine and guanine) to reduce the amino acid codon number and the 
amount of possible stop codon integration from three to one (TAG). After library 
construction, ten individual mutants, as well as one aliquot of a mixed library 
preparation were sequenced. Figure 20 shows the sequencing results for a pool of 
library 1 (A) plus ten randomly chosen loop-mutants (B). SNAP-tag was correctly 
modified at position 159/160 and loop sequences were randomized. No stop codons 
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were found and only mutant 10 showed a frame shift, most probably due to an error in 
primer synthesis. 
 
 
Figure 20: Diversity control of loop library 1. Seven random amino acids have been introduced replacing residue 
159/160 of SNAP-tag. A: Chromatogram of the library pool highlighting the randomized region. B: Sequencing 
results of ten randomly chosen plasmids confirming the diversity of the library. 
The test sequencing of library 2, in which eight randomized amino acids were 
introduced at position 32/33 showed that four out of ten mutants carried a stop codon 
and one sequence was isolated twice (Figure 21). Due to these findings the diversity 
of full-length SNAP-mutants in library 2 was expected to be inferior to the diversity 
of library 1.  
 
A.:
B:
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Figure 21: Diversity control of loop library 2. The mutants carry a loop consisting of eight randomized amino 
acids including amino acids 32 and 33 of SNAP-tag. A: Chromatogram of the library pool highlighting the 
randomized region, B: Sequencing results of ten randomly chosen mutants, four carry a stop codon. 
The SNAP-mutant libraries were transformed in E.coli XL1-blue cells to give a total 
complexity of 6.0x107 for library 1, 4.4x107 for library 2 and 5.0x107 for the C-
terminal library 3. DNA stocks of the libraries were generated and used for large-
scale transformation in yeast (Table 2). For each bait-protein a separate 
transformation was performed and the complexity of the yeast stock determined. 
1.0x107 different clones from each library were screened against each bait-protein. 
Like that about 20 % of the initial E.coli library complexities were covered in this 
setup. 
B:
A:
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Table 2: Library sizes in yeast for all bait-proteins used in the screening. 15 μg of DNA originating from the 
E.coli stock were used for large-scale yeast transformation and the transformation efficiencies determined. In the 
yeast screening 1x107 different mutants were plated on each screening plate, which covered about 20% of the 
initial library complexities in E.coli. 
 
3.3 Optimization of screening conditions 
The optimization of the screening conditions comprised the reduction of non-specific 
background growth to an acceptable level, the confirmation of bait-protein expression 
in yeast and the determination of auto-activation for each bait protein. Further, the 
labeling efficiency of BG-derivatized inhibitor molecules was quantified in yeast 
cells.  
3.3.1 Bait-proteins 
The bacterial enzyme dihydrofolate reductase (eDHFR) and the human protein polo-
like kinase 4 (Plk4) were chosen as target proteins. eDHFR was well suited for a 
proof-of-concept experiment of the yeast two-hybrid- and three-hybrid approach, as 
point mutations introduced in eDHFR were shown to modify the binding affinity 
towards the small molecule inhibitor methotrexate (Mtx) from sub-nanomolar (wild-
type protein) to around micromolar for the weakest mutant (Val31Gly54 
mutation)155,156. The moderate binding affinity to Mtx should be beneficial for the 
detection of loop-dependent binding.  
Plk4, the second bait-protein, is important for proper centriole duplication, as 
silencing results in disorganized mitotic spindles and apoptosis 157. The kinase seemed 
a particularly relevant choice for our approach, as no specific small molecule 
inhibitors were available at that time. Besides binding specificity, SNAP-based 
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protein inhibition offered important advantages over existing methods. The loop-
mediated binding targets the native form of Plk4. Compared to kinase depletion using 
siRNA, which takes approximately one to two days, SNAP-mediated inhibition 
depends on the protein labeling and therefore has a higher temporal resolution of 
several minutes to hours which would allow for the inhibition of Plk4 at distinct time 
points of the cell cycle.  
3.3.2 Bait-protein expression in yeast 
eDHFR and eDHFR mutants (eDHFRIle54, eDHFRGly54 and eDHFRVal31Gly54) were 
expressed in yeast as C-terminal fusion proteins to the DNA-binding protein LexA.  
For Plk4 two constructs of the kinase domain (residues 1-88 and 1-130 (design based 
on Leung et al.158) and the full-length protein were fused to LexA in the same way as 
eDHFR. The fusion proteins were expressed in yeast and analyzed by Western blot on 
cellular lysates using a LexA specific antibody (Figure 22).  The analysis showed that 
all proteins were expressed as full-length constructs and could therefore be used for 
the screening. 
 
3.3.3 Bait auto-activation 
The level of HIS3-reporter gene activation was measured for each bait-protein. 
Therefore, the individual bait-proteins fused to the DNA-binding domain LexA were 
Figure 22: Bait protein expression confirmed by Western Blot against LexA. Bands correspond to the expected
size of bait proteins. A: Analysis of eDHFR and DHFR-mutants, B: Analysis of Plk4-constructs. 
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co-expressed with either GAL4 from the empty prey vector (pGAD-HA, 
Dualsystems) or with the fusion protein SNAP-Gal4.  
No auto-activation could be detected for eDHFR and DHFR-mutants, as growth on 
selective medium did not yield any colonies. Even in the presence of SNAP-tag no 
reporter gene transcription was observed (Table 3). 
 
Table 3: Bait auto-activation of eDHFR and mutants. Incubation on non-selective media gave several hundred 
colonies. The same number of cells plated on selective media did not yield any single colony, confirming the 
absence of reporter gene activation by eDHFR and mutants. 
However, all Plk4 constructs showed some auto-activating properties, especially in 
the presence of SNAP-tag (Table 4). The long version of Plk4 kinase domain (Plk4-
KDlong) was strongly activating and was excluded from the screening.  
Prey plasmid 
 
Medium Bait plasmid (Number of colonies) 
  eDHFR DHFR
Ile54 DHFRGly54 DHFRVal31Gly54 
Non 
selective 
150 250 290 136 
Empty 
selective 0 0 0 0 
Non 
selective 
240 190 177 190 
SNAP-fusion 
selective 0 0 0 0 
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Table 4: Auto-activation of transporter gene transcription of Plk4-constructs and the interacting pair p53-largeT as 
positive control. The co-expression with Gal4 (empty plasmid) under selective conditions gave between one and 
six colonies. This number increased further when SNAP-Gal4 was co-expressed with the bait-protein.  
3.3.4 Pilot screens: 
Pilot screens of all bait constructs with SNAP-tag-Gal4 were performed to determine 
the screening conditions for the lowest possible background growth.  
Besides changes in the fusion-protein construct two other parameters can be modified 
to reduce background growth. One is the total amount of cells plated on solid agar, the 
second the concentration of 3-amino-1,2,4-triazole (3-AT), a competitive inhibitor of 
imidazolglycerol-phosphate dehydratase, the product of the HIS3 reporter-gene. In 
order to determine the optimal 3-AT concentration for each bait protein, yeast cells 
were incubated with increasing amounts of 3-AT (from 0 to 5 mM for DHFR and 0 to 
10 mM for Plk4). Yeast cells expressing DHFRGly54LexA or DHFRIle31Gly54LexA plus 
SNAP-Gal4 showed only little background growth (Figure 23). According to these 
results, a concentration of 0.5 mM 3-AT was sufficient to limit background growth.  
 
Prey plasmid 
 
Medium Bait plasmid (Number of colonies) 
  
Plk4-
KDshort 
Plk4-
KDlong 
Plk4 
p53 
(positive ctrl.) 
Non 
selective 
130 190 80 136 
Empty 
selective 1 1 6 0 
Non 
selective 
136 108 38  
SNAP-fusion 
selective 28 60 2  
Non 
selective 
   260 LargeT-
fusion 
selective    95 
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Figure 23: Pilot screen for DHFRGly54 or DHFRVal31Gly54 expressing yeast cells. A concentration of 0.5 mM 
3-AT is sufficient to fully inhibit background growth (indicated by the black arrows). 
For Plk4-constructs, where a stronger auto-activation had been observed previously, 
the amount of 3-AT had to be increased to 1 mM for Plk4 full-length and up to 5 mM 
3-AT for Plk4 kinase-domainshort to limit background growth to an acceptable level 
(Figure 24).  
 
 
Figure 24: Pilot screen of Plk4 full-length and Plk4 kinase-domain. Both show higher background growth then 
DHFR and screening was performed in the presence of 3-AT. Flashes indicate 3-AT concentrations for each bait-
construct respectively.  
3.3.5 Growth dependency of eDHFH and DHFR-mutants  
The binding of Mtx to eDHFR is a strong interaction in the low nanomolar range. The 
engineered mutants of eDHFR showed a decreased binding affinity for the inhibitor in 
0 mM 5 mM2.5 mM1 mM0.5 mM
DHFR
3-AT
Gly54
DHFRVal31Gly54
0 mM 10 mM5 mM2.5 mM1 mM
Plk4
full-length
Plk4-KD
3-AT
 Results – SNAP-based Inhibitor of Protein Function 
 
 45 
the low micromolar range 155 156. We wanted to test if the decrease in small molecule 
binding affinity could be reflected in a decrease of yeast growth. In that way it would 
be possible to differentiate between weak and strong binding interactions based on 
different concentrations of the small molecule. 
The growth dependency study in yeast confirmed the modulated binding affinities of 
eDHFR-mutants for Mtx (Figure 25). We were able to trigger yeast growth on 
selective media by titratration of the BG-Mtx concentration. Cells expressing the 
weakest binding mutant eDHFRVal31Gly54 did not grow, even at a concentration of 10 
μM BG-Mtx. A decrease in the concentration down to 1 μM inhibited growth of cells 
expressing the mutant eDHFRGly54 that has intermediate affinity for Mtx. Further 
dilution of the compound to the nanomolar range stopped yeast growth of all mutants 
and the wild-type.  
The two weakest binding mutants, eDHFRGly54 and eDHFRVal31Gly54 were chosen for 
the screening, as they showed a good growth responds to changes of BG-Mtx 
concentration. At the same time a sufficiently high BG-Mtx concentration could be 
used to ensure the presence of a certain amount of labeled SNAP-mutants inside the 
cells.  
 
Figure 25: Growth of wild-type eDHFR and DHFR mutants depends on BG-Mtx concentration on selective 
medium. At a concentration of 1 μM and 10 μM BG-Mtx, growth of eDHFRGly54 and eDHFRVal31Gly54 was no 
observed. These conditions were used fro the SNAP-tag library screen and the DHFR-Mtx interaction alone should 
not lead to cell growth. 
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3.3.6 Small molecule labeling efficiency in yeast 
The small molecule labeling efficiency inside yeast cells is an important parameter for 
the Y3H screening.  
The assessment of the intracellular labeling efficiency was based on the expression of 
a CLIP-SNAP fusion protein in yeast cells (Figure 26). CLIP-tag is an orthogonal 
self-labeling protein tag to SNAP-tag, which covalently reacts with benzylcytosine 
(BC) derivatives 30. The method involves the following steps: (i) incubation of intact 
yeast cells expressing CLIP-SNAP with a BG-derivative of interest to (partially) label 
SNAP-tag either in liquid medium or on solid agar plates; (ii) cell lysis in the 
presence of BG-Cy5 and BC-Cy3 leading to the complete labeling of CLIP-tag and 
the remaining SNAP-tag in the cell lysate; (iii) SDS-PAGE and in-gel fluorescence 
analysis to calculate the labeling efficiency of BG-inhibitor from the ratio of Cy5/Cy3 
fluorescence intensities of the CLIP-SNAP fusion protein. The calculation requires 
the ratio of fluorescence intensities of a control sample not incubated with BG-
inhibitor to set the 0% labeling reference. CLIP-tag serves as an internal reference to 
account for variations in fusion protein quantities over samples. 
 
 
Figure 26: Overview of the assay to determine intracellular SNAP-tag labeling efficiency by SNAP-CLIP fusion 
protein labeling. ACT-AGT dimers are expressed in yeast cells and incubated with a BG-substrate, whose labeling 
efficiency should be assessed. At the end of incubation, cells are washed and a mixture of BG-Cy5, BG-Cy3 is 
added to the cells. After lysis and further incubation to reach complete labelling, the reaction is quenched by the 
addition of a large excess of free BG. Sample buffer is added and the labeling efficiency is determined via SDS-
PAGE analysis and quantification of fluorescence signal intensity.   
The permeability of BG-Mtx was determined previously153. Here, the labeling 
efficiency of PP1 was assessed. PP1 is a kinase inhibitor molecule, which was linked 
to BG via three different linker moieties (Figure 27). The molecules were provided by 
Dr. Eveline Müller153. The labeling efficiencies in liquid and on solid medium 
measured with this method should provide a good estimate of the labeling efficiencies 
in Y3H screenings.  
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Figure 27: BG-PP1 derivatives with variations in linker length. These molecules were tested for their labeling 
efficiencies inside yeast cells. 
The results clearly showed that the labeling efficiency strongly depends on the linker 
that was used to attach BG to Mtx (Table 5). An alkyl chain linker was preferred over 
polyethylenglycol (PEG) units (compare EM234 versus EM125). At a concentration 
of 50 μM BG-PP1 labeling efficiencies were slightly higher than for a concentration 
of 10 μM. On solid medium, labeling efficiencies were superior to those in liquid 
culture, which can be explained by the prolonged incubation times necessary for yeast 
growth on solid media. According to these results it had to be considered that only a 
part of the mutants would be present in their labeled state during Y3H screening. 
 
Table 5: Summary of intracellular labeling efficiencies of the three tested molecules, EM125, EM123 and EM127 
at two different concentrations (10 and 50 μM) in liquid and on solid media. 
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3.3.7 Test screening  
According to the results obtained from the optimization procedures, a BG-Mtx 
concentration of 1 μM together with eDHFRGly54 and eDHFRIle31Gly54 was chosen as 
starting conditions for the screen. Fixing the BG-Mtx concentration close to the 
dissociation constants should increase the sensitivity for SNAP-tag loop binding, as 
the eDHFR-Mtx interaction should not be sufficiently strong to trigger yeast growth. 
Table 6 summarizes the results from each screening plate. Strong background growth 
was observed and several plates could not be evaluated. Sequencing of randomly 
chosen colonies showed that a high number of mutants carried a stop-codon and 
interactions were not reproducible in fresh yeast cells (data not shown). 
 
Table 6: Screening output of test screening against eDHFR at a 3-AT concentration of 0.5 mM. For the C-terminal 
library and DHFRVal31Gly54 with library 1 a strong background growth was observed. For all other screening plates 
between 23 and 178 colonies were detected. Further analysis identified them as false-positive interactions.  
 
In order to improve the screening output two modifications were tested. First, the 
concentration of BG-Mtx on the screening plates was increased to 10 μM to improve 
the intracellular labeling of the mutants. Second, selection stringency was increased 
using a higher 3-AT concentration of 2.5 mM.  
The augmentation of BG-Mtx concentration did not improve the screening output. 
Around 20 colonies were detected on the screening plates but further analysis 
identified all of them as false-positive interactions (data not shown). The increase of 
3-AT concentration improved the screening output, as mutants with bait-specific 
interaction were identified. However, no dependence on BG-Mtx was detected in 
colony respotting.  
Number of colonies on screening plate 
 library 
BG-Mtx (1 μM) control (DMSO only) 
1 178 134 
2 30 35 DHFR
Gly54 
C-terminal strong background strong background 
1 strong background strong background 
2 23 28 DHFRVal31Gly54 
C-terminal strong background strong background 
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3.4 Screening against eDHFR 
According to the results obtained in the test screening of eDHFR, higher 
concentrations of 3-AT were needed for sufficient background suppression. 
Therefore, the screening of all SNAP-libraries was done using the optimized 
conditions.  
As a consequence, the overall number of colonies decreased to not more than 30 
colonies per plate (Table 7). The highest number of colonies was detected for the C-
terminal library, for loop libraries 1 and 2 the colony number further decreased.  
 
Table 7: Screening output under improved screening conditions. The stringency of screening was increased by a 
3-AT concentration of 2.5 mM. As a consequence, the number of colonies drastically decreased compared to the 
first screening attempt. At the same time the quality of the detected colonies improved strongly as interactions 
were reproducible in fresh yeast cells. 
The colonies were tested for BG-Mtx dependency and for their strength of reporter 
gene activation. No dependency on BG-Mtx could be observed as all colonies grew 
on selective medium not containing any BG-Mtx (Figure 28).  
Number of colonies on screening plate 
 
library 1 μM BG-Mtx 
1 8 
2 0 DHFRGly54 
C-terminal 32 
1 2 
2 7 DHFRVal31Gly54 
C-terminal 18 
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Figure 28: Respotting of colonies identified in eDHFR screening on selective medium with and without BG-Mtx. 
All identified hits were directly interacting with the bait-protein and no molecule-dependent interactions could be 
detected. 
For the assessment of reporter gene activation cells were spotted on selective medium 
containing increasing amounts of 3-AT. The number of colonies decreased with 
increasing 3-AT concentration and at 2.5 mM 3-AT only eleven out of 67 hits showed 
good colony growth. Retransformation of the eleven mutants in fresh yeast cells 
resulted in a reproducible colony growth (Table 8). Sequencing analysis identified 
one loop mutant originating from library 1 and five mutants of the C-terminal library.  
 
Table 8: Increase of 3-AT concentration improved output of library screening against eDHFR. One loop-mutant 
and five C-terminal mutants were isolated that all showed good growth at 2.5 mM 3-AT. The loop mutant was 
identified twice from the screening, the C-terminal mutants were identified between one and four-times. 
The sequence analysis of the C-terminal mutants further revealed that several amino 
acids in the C-terminal peptide-tail were conserved (Figure 29). All mutants carried a 
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serine residue at position 2, an arginine at position 4 and a tryptophan at position 6. 
On the third position a valine was preferred.  
 
Figure 29: A: Sequence alignment of SNAP-tag with C-terminal mutants C1-C5. Colonies isolated showed a 
conserved motive. Most of the amino acids use different codons, B. “Sequence logo” for isolated hits C1 to C5.  
It is generally a good indicator for the screening process if the isolated sequences 
contain the same amino acids at conserved positions of a peptide. The fact that these 
amino acids were coded by different DNA-triplets only strengthened this point. 
Figure 30 illustrates the sequence alignment of the isolated loop-mutant named Loop1 
with SNAP-tag for the residues 157 to 163.  
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Figure 30: Sequence alignment of SNAP-tag and isolated mutant Loop1 that was isolated from the screening at 
higher 3-AT concentrations. 
3.4.1 Bait specificity of eDHFR hits in yeast 
The isolated hits were tested for their specificity by including several negative 
controls, which did not lead to colony growth (Figure 31). In the first experiment only 
cells expressing Loop1 together with either eDHFR or eDHFRG54 were able to form 
colonies on selective medium. This result confirmed the specific bait-prey interaction 
in yeast between eDHFR (-mutants) and Loop1.?
 
Figure 31: Bait-dependency test for Loop1. Serial dilutions of yeast cells (top to bottom) expressing Loop1 and 
different bait proteins (1-7) were spotted on non-selective (left) and selective medium (right). eDHFR-dependent 
growth of Loop1 was confirmed. Co-expression of LexA, the eDHFR-fusion protein used in the screening, did not 
trigger yeast growth.  
Analysis of the C-terminal SNAP-mutants showed consistent results (Figure 32). 
Colonies expressing the SNAP-mutants C1 to C5 were co-transformed with the same 
bait-proteins than Loop1. Only co-expression of eDHFR and C1 to C5 resulted in 
yeast growth on selective medium. 
 
 
 
SNAP-tag
loop1
158157 159 160 161 162 163
?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
?????????????????????????? ???????????????????????
??
???
???
???
???
??
???????
????????????????
???????????
??????????????????????????
????????????????????????
?????????????
????????????????
 Results – SNAP-based Inhibitor of Protein Function 
 
 53 
  
Figure 32: Bait-specificity study for C-terminal mutants C1-C5. Bait-proteins from left to right:1. LexA, 2. LexA-
SNAP-tag, 3. LexA-p53, 4. LexA-Plk4 kinase domain, 5. Plk4 full length, 6. LexA-eDHFR. Only co-expression of 
C-terminal mutants and LexA-eDHFR triggered yeast growth.  
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3.5 Screening against Plk4 
Polo-like kinase 4 (Plk4) is one of the four members of the Polo-like family and plays 
an essential role in centriole duplication 159,160. It is essential for embryonic 
development 161. Overexpression is leading to multiple centriole formation in the cell. 
Compared to the other Polo-like kinases Plk4 is the structurally most different 
member. It carries only one Polo-box domain instead of two and has an additional 
crypto Polo-box domain. Both of these domains could be shown to be important for 
anchoring Plk4 to the centrosome. Furthermore, the homodimerization of the Polo-
box domain regulates Plk4 kinase activity 162. 
Plk4 stability is governed by three PEST sequences, one within the amino terminus 
and two within the carboxy terminus of Plk4. These regions are rich in proline (P), 
glutamate (E), serine (S) and threonine (T) residues and are associated with short 
intracellular half-lives of proteins 163,164. Autophosphorylation plays an important role 
in regulating the stability of the kinase as trans phosphorylation of the Plk4 dimer 
complex targets the kinase for degradation 165.  
Plk4 phosphorylates in a context-dependent manner where the residues surrounding 
the phosphorylation site play an important role for its ability of substrate 
phosphorylation 158. Studies on the phosphorylation motive could identify some 
common elements important for substrate recognition 158,166,167. There is evidence that 
Plk4 might also play a role in other processes than centriole duplication. As many 
questions remain to be answered more work on this kinase is needed. The 
identification of SNAP-loop mutants binding to Plk4 might therefore allow new 
insights on substrate binding interactions and the identification of possible 
phosphorylation motives. 
The screening of the loop-libraries against Plk4 was performed in a similar setup than 
the eDHFR screening. The same concentration of 3-AT was used and the screening 
was performed in three different settings: First, without the addition of a small 
molecule (Y2H-setting), second with 10 μM of the small molecule EM125 and third 
with the addition of 5 μM of the small molecule EM234 (for structures see Figure 27).  
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In total 384 colonies could be isolated from the screening and in general, more 
colonies were detected on selection plates containing a small molecule than on plates 
without molecule (Table 9).  
 
Table 9: Colonies obtained from Plk4 screening at 2.5 mM 3-AT concentration. More colonies were obtained on 
plates that were supplemented with BG-inhibitor than on plates not containing any molecule.  
However, the respotting on plates with and without BG-inhibitor molecules did not 
reveal any colonies, whose interaction would depend on the presence of the small 
molecule. All colonies grew on selective medium and only the titration with 3-AT 
reduced the colony number (Figure 33). Out of 384 isolated colonies 107 grew at a 3-
AT concentration of 5 mM and were further considered as potential hits from which 
plasmids were isolated.   
 
Figure 33: 3-AT titration reduced colony number. Only colonies that grew at 5 mM 3-AT were considered as 
potential hits and further analyzed.   
 
library Number of colonies 
 no molecule 10 μM BG-EM125 5 μM BG-EM234 
1 40 57 50 
2 8 96 96 
Plk4 full 
length 
3 31 39 46 
selective medium, 0 mM 3-AT selective medium, 5 mM 3-AT
384 colonies 107 colonies 
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3.5.1 Bait-specificity of Plk4 hits in yeast 
The isolated hits were tested for their bait specificity by including three negative 
controls (Figure 34). As several hundred transformations had to be carried out a yeast-
transformation robot was used (kindly provided by Prof. Bart Deplancke at EPF 
Lausanne). The output of the bait-specificity analysis showed that the majority of 
colonies were dependent on Plk4. A few colonies were positive for the protein LexA 
and only four yeast colonies seemed to be generally activated as they grew under all 
tested conditions. This behavior probably arose through yeast mutations, which 
circumvented the selection via HIS3 reporter gene activation. Only colonies that grew 
in a bait-specific manner were considered for further analysis and sequencing.  
Sequencing identified 15 different SNAP-mutants, ten out of library 1 (loop position 
159/160) and five out of library 2 (loop position 32/33) (Table 10).  
 
 
Figure 34: Bait-specificity test of mutants identified in the screening against Plk4. Different bait-plasmids were 
co-transformed, only one carrying the Plk4 gene. Growth on non-selective media (left picture) showed that yeast 
manipulation did not affect its general viability. Incubation under selective conditions (right picture) identified 
several false-positive interactions that were not specific for the bait-protein Plk4, but the majority of identified 
colonies grew in a bait-dependent manner. 
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Table 10:  Output of Plk4 screening with 2.5 mM 3-AT on screening plates.  
In general, a higher number of sequences were identified for loop library 1. Mutants 
L7, L8, L12 and L14 had the particularity to carry especially long randomized 
sequences. This had not been observed during the DHFR screening despite the fact 
that the same library stocks had been used.  
Several sequences were sufficiently similar to be considered as one common sequence 
motive (Figure 35). In some cases inversions of amino acids were found, but overall 
L2, L4, L8 and L12 were considered as one motive (Trp-Ala-Val-(Thr-Ile)). L10, L13 
form a second core motive (Met-Ala-Arg-Gln-Ile) and L7, L14 build the third motive 
block. 
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Figure 35: Conserved motives identified in Plk4 screening. Three major sequence blocks could be identified as 
putative binding sequences. Some sequences (L7 and L8) were isolated in high quantity, whereas others were 
isolated only once. The first motive (L2, L4, L8 and L12) was found in both libraries 1 and 2. 
Interestingly, the closer examination of mutant L7 and L14 showed a very high 
sequence similarity with a part of the Plk4 kinase domain itself (Figure 36). Five or 
seven amino acids out of 15 aligned with the residues of Plk4.  
Data published by Sillibourne et al. on the autophosphorylation of Plk4 reported the 
phosphorylation of the serine residue upfront to this sequence167 (Figure 36, marked 
in red). Additionally, the authors reported the preference for a peptide length of 12-13 
amino acids as phosphorylation substrate, which might explain why mutants with 
longer peptide loops had been identified in our screening. It is possible that the 
peptides of L7 and L14 were recognized by Plk4 and potentially serve as 
phosphorylation substrate, as threonine and serine residues were present. However 
this hypothesis needs further experimental confirmation. 
  
 
Figure 36: Sequence alignment of Plk4 kinase domain (residues 201-215) and loop peptide sequences of L7 and 
L14. The serine highlighted in red is known to be autophosphorylated. Loop peptides contain either threonine or 
additional serine (italic), which might be phosphorylated by Plk4.  
Plk4 S L G C M F Y T L L I G R P P  
L7  G F G C G R V T F L I I L S W 
L14  G F G C G R V T L L L I R R W 
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The especially long randomized sequences that were isolated in the Plk4 screening 
arose through errors in loop primer synthesis. Two examples are given in Figure 37. 
In the case of mutant L7 the presence of three additional guanine-bases resulted in the 
introduction of additional mutations from amino acid 152 on. For mutant L12 three 
bases were missing. The consequence of this was that additional mutations were 
introduced from position 154 on. However, after amino acid 160 all sequences 
aligned to the original SNAP-tag sequence coding for the full-length protein.   
 
Figure 37: Errors in primer synthesis were the reason for the existence of SNAP-mutants with more than eight 
mutations. Mutant L7 is lacking three guanine bases upfront to the NNK-part of the primer and amino acids were 
mutated from residue 152 on. Mutant L12 has three missing bases and mutations start at amino acid 154. From 
residue 161 on all mutants are correctly aligning to the SNAP-tag sequence. 
In SNAP-tag residues 152 and 154 are implicated in a hydrogen-bond network that is 
stabilizing the protein. The consequences of the introduced mutations are difficult to 
predict but they may have an influence on protein reactivity and structure. However, 
additional experiments on protein labeling and stability are needed to draw further 
conclusions. 
This primer “defect” represented a minor population of the library pool, as it was 
neither observed in the test sequencing during library construction, nor in the eDHFR-
screening process. Nevertheless, these mutants were isolated frequently in the Plk4 
screening and show certain sequence conservation in the randomized part. 
GGG GAT TTG GAT GTG GGC GGT TAC GAG --- --- --- --- --- --- GTT GGA SNAP-tag
G D L D V G G Y E G G
GGG GGA TTT GGA TGG GGG CGG GTT ACC TTT TTA ATC ATC TTA AGC TGG GGA L7
G G G G GF C R V T F L LI I S W
GGG GAT TTG GTG TGG GCG GTT ACA ATT TTT GTC CGC AGC CTT --- TGG GGA
G GD L L WV V VW T I SRFA
L12
NNK-primer5’ 3’
SNAP-tag complementary part NNK-part for loop
151 152 153 154 155 156 157 158 159 160 161 residue number
additional guanine bases
missing basesA G G
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3.6 In vitro analysis of confirmed hits 
The majority of isolated mutants showed a bait-dependent growth in yeast. The next 
step consisted in the confirmation of protein-protein interaction in vitro and in the 
further characterization of the mutants regarding protein reactivity, stability and 
inhibitory activity.  
 
3.6.1 Labeling of SNAP-mutants with BG-substrates 
Loop-mutants identified during the Plk4-screening were expressed in E.coli cells as 
GST-fusion proteins and the lysate was incubated with three BG-substrates that 
differed in size, fluorophore and linker architecture (Figure 38).  
 
 
 
Figure 38: BG-substrate labeling of SNAP-loop mutants isolated during the Plk4 screening. The mutants were 
incubated with different BG-substrates (A, B or C). Labeling was observed for mutants from library 2 only (L2 
and L6). This indicates that position 32/33 is generally better suited for loop-insertion and yields reactive mutants, 
whereas modifications at position 159/160 (mutants L10, L13 and L14) have a strong impact on the reactivity. 
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Protein labeling was assessed by fluorescence-in-gel analysis. From kinetic studies on 
SNAP-tag we knew that BG-fluorescein (molecule A) has good kinetics and is 
showing efficient labeling. Modification of BG-molecules with PEG-units was shown 
to reduce labeling efficiency for SNAP-tag and molecules B and C were chosen to 
assess this influence on the loop-mutants.  
Our analysis showed that SNAP-tag modification in library 1 had a negative effect on 
protein reactivity. None of the mutants having a loop-insertion at position 159/160 
were reacting with any BG-molecule (L10, L13 and L14). However, for library 2 in 
which the loop was placed between residues 32/33 (L1 and L5), protein labeling 
could be observed for all tested molecules, even though band intensities were weaker 
for compound B and C at equal protein concentrations.  
 
3.6.2 GST pull-down with C-terminal SNAP-tag mutants 
The interaction with eDHFR was analysed in vitro by pull-down experiments. eDHFR 
was detected by Western blotting using a his-tag antibody (Figure 39). The 
experiment confirmed the interaction of the C-terminal mutants with eDHFR only in 
the presence of BG-Mtx. Band intensities of the pull-down samples without the BG-
derivative were not significantly stronger than the background. This indicated that the 
potential interactions were not strong enough to be detected by a pull-down. 
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Figure 39: Pull-down experiment using his-tagged eDHFR with C-terminal mutants and SNAP-tag before and 
after labeling with BG-methotrexate. Band intensities of the input of eDHFR correspond to a 1:10 dilution.   
3.6.3 Further characterization of mutant Loop1  
The mutant Loop1 was the only loop mutant isolated during the screening against 
eDHFR. As the bait-dependency test in yeast confirmed the interaction with eDHFR, 
it was analyzed by additional in vitro experiments. We decided to use a cross-linking 
approach to determine the interaction between Loop1 and eDHFR. Additionally, 
Loop1 was analyzed for BG-substrate reactivity, protein stability and inhibitor 
activity using an eDHFR-activity assay.   
 
Cross-linking of eDHFR and Loop1. Protein binding of Loop1 to eDHFR was 
determined by SNAP-based cross-linking30 (Figure 40). The working principle is the 
physical cross-linking of two interacting proteins mediated by SNAP-tag labeling 
using a BG-cross-linker. In the case of protein interaction the formation of a 
heterodimer can be detected on a SDS-PAGE.  
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For the protein pair eDHFR-Loop1, GST-tagged eDHFR and his-tagged Loop1 were 
expressed as fusion proteins to SNAP-tag. After incubation with BG-cross-linker the 
samples were analyzed for their in-gel-fluorescence intensity on a SDS-PAGE (Figure 
41). 
 
Figure 40: Working principle of SNAP-based cross-linking using a BG-cross-linker and two SNAP-tag fusion 
proteins. If eDHFR interacts with Loop1 the formation of the heterodimer can be resolved on a SDS-PAGE. As 
control a SNAP-SNAP fusion protein was included in the experiment. 
 
Figure 41: Loop1-eDHFR cross-linking experiment. Proteins were incubated with BG-TMR-TMR-BG (LR223) 
cross-linker and analyzed by SDS-PAGE. A band of the corresponding size of the hetero-cross-linking product of 
eDHFR and Loop1 was detected. Quantification showed that signal intensity was significantly higher than the 
control (cross-link of SNAP-eDHFR) confirming the interaction between Loop1 and eDHFR in vitro. 
A cross-linking band for Loop1 and eDHFR fusion proteins could be observed and 
the presence of both proteins (eDHFR and Loop1) was confirmed by Western blot 
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analysis (data not shown). Quantification of band intensities and comparison with the 
control experiment (unspecific cross-link between SNAP-tag and eDHFR) confirmed 
the interaction between Loop1 and eDHFR, as signal intensities were significantly 
higher for Loop1 than for SNAP-tag. 
Protein stability determination of Loop1. The insertion of additional amino acids in 
a given protein structure can have a strong effect on the protein folding and on protein 
stability. Therefore, the protein melting-temperatures of Loop1 in comparison to 
hAGT and SNAP-tag were determined to assess the degree of destabilization (Figure 
42). As expected, SNAP-tag turned out to be the most stable protein, with a melting 
point temperature of 69°C. The modifications introduced in Loop1 reduced the 
melting point by 7 degrees to 62°C. Loop insertion did decrease protein stability but 
compared to hAGT (melting point of 55°C) Loop1 is still more stable.  
 
Figure 42: Loop1 is a stable protein. Melting-point analysis of hAGT, SNAP-tag and Loop1 showed that SNAP-
tag possesses the highest stability, with a TM of 69°C. Loop1 has a melting point of 62°C, which is seven degrees 
higher than the wild-type protein hAGT. 
 
Reactivity of Loop1 with BG-substrates. The positions of loop-insertion in SNAP-
tag were based on previous work done in our group154. Even though important 
structural units were left unchanged, the loop-insertion at position 159/160 of SNAP-
tag had an influence on protein reactivity with BG-substrates. Loop1 was incubated 
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with four different BG-substrates and the labeling efficiency was recorded over time. 
The reactivity of Loop1 was impaired for all substrates (Figure 43). 
 
 
 
 
Figure 43: Labeling efficiency of Loop1 with different BG-substrates. SNAP-tag labeling with BG-fluorescein  
(?; BG-FL) was taken for comparison. The insertion of Loop1-motive at position 159/160 had an impact on 
Loop1 labeling efficiency, which was decreased 28-fold for BG-FL. Reactivity with BG-TMR was 4-fold slower 
than reaction with BG-FL. The reaction with BG-substrates containing PEG-units as linker-moieties did not take 
place. Steric hindrance might be a possible explanation for this phenomenon. 
BG-fluorescein (BG-FL) reacted 28-fold slower than SNAP-tag. Reaction with BG-
TMR was around four-fold slower than reaction with BG-FL and incubation with BG-
PEG-Mtx or BG-C4-malachite green (BG-C4-MG) did not yield any labeled protein. 
This result shows that the introduction of additional amino acids at position 159/160 
of SNAP-tag had a major impact on reactivity. This result limited the scope of 
application for Loop1 as it was not reacting with BG-Mtx and therefore not possible 
to assemble the inhibitory complex intended for eDHFR inhibition. However, the 
inhibitory activity of Loop1 itself against eDHFR was tested in an activity assay. 
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eDHFR activity assay. eDHFR activity was determined by monitoring the reduction 
of dihydrofolic acid to tetrahydrofolic acid using NADPH as electron donor. The 
consumption of NADPH leads to a change in absorption at 340 nm. Upon addition of 
increasing amounts of Loop1 the catalytic activity of eDHFR was decreased (Figure 
44). The apparent inhibitory concentration (IC50,app.) was in the micromolar range (≈ 
10 μM), which showed that the Y2H screen had identified a weak affinity binder. 
However, in the control experiment using increasing amounts of SNAP-tag no 
inhibition of eDHFR could be observed. As the C-terminal mutants C1-C5 had some 
degree of sequence similarity with Loop1 they were tested for eDHFR inhibiton as 
well. Interestingly, the addition of increasing amounts of C-terminal SNAP-mutants 
did not result in inhibition of eDHFR activity. 
 
Figure 44: eDHFR-activity assay with SNAP-tag, Loop1 and C-terminal mutants C1 to C5. Even though sequence 
similarities between Loop1 and C-terminal mutants exist, only Loop1 inhibited the catalytic activity of eDHFR 
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4 Discussion 
4.1 New insights on structural aspects of hAGT and SNAP-tag 
In the first part of the current thesis we investigated the structural basis underlying the 
differences in protein stability between SNAP-tag and its parent protein hAGT. We 
could demonstrate that SNAP-tag displays not only an increased reactivity with O6-
modified benzylguanine-derivatives but also had a superior stability than the parent 
molecule. Moreover, the combination of our crystallography and molecular modeling 
data provided further insight into the structural basis of the improved properties of 
SNAP-tag.  
Generally, the evolution of proteins favors the selection of marginal stability with 
improvements in functionality 168. It is also known from other directed evolution 
experiments, that activating mutations usually come at the cost of stability 169 170. As 
most mutations are destabilizing and since evolution favors the most likely solutions 
over less likely ones, (directed) evolution generally favors mutants with marginal 
stability. Surprisingly, our study showed that the directed evolution of wild-type 
hAGT into SNAP-tag did not only increase the reactivity of the protein towards BG, 
but also affected the stability of unlabeled and, in particular labeled SNAP-tag. This 
gain of stability is even more remarkable when we consider that directed evolution 
experiments were focused on increased SNAP-tag reactivity, but not its higher 
stability. We believe that in the particular case of hAGT evolution, the reason for 
improved stability is due to the fact that higher stability also influenced the reaction 
rate of the protein. Furthermore, the increased in vitro stability translates well into 
prolonged protein half-life in mammalian cells, as no significant SNAP-tag 
degradation was detected at more than 40 hours upon labeling. This is in direct 
contrast to the behavior of wild-type hAGT, which becomes rapidly degraded (half-
life of 3 hours) upon alkylation171. Reasons for this different behavior can be readily 
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explained by our analyses of the protein. The evolution from hAGT to SNAP-tag 
included 19 point mutations and the shortening by 25 amino acids at the protein’s C-
terminus. The analysis of SNAP-tag crystal structures showed as expected, that 
despite such drastic changes in the primary amino acid sequence, the overall protein-
folding characteristic to hAGT was preserved. A detailed investigation of the single 
amino acid changes and the characterization of the intermediate mutants enabled us to 
identify important amino acid positions determining an increased stability and 
improved reactivity.  
It is an intriguing particularity of alkylguanine-transferases in general to carry highly 
conserved glycine resides in the middle of an alpha helix, which plays an important 
role in substrate binding (the so-called recognition helix)150,151. Similarly to the 
human protein, AGT orthologues in other organisms share at least one or two glycine 
residues incorporated at the same position of the corresponding alpha helix (Figure 
45). It has been argued that the role of the glycine residues at this position is to 
accommodate the natural substrate, an alkylated guanine flipped out of double-
stranded DNA143.  
 
Figure 45: Sequence alignment of AGTs from different organisms. Figure taken from Tubbs et al.172 and 
modified. 
However, changes introduced in AGT-54 at positions 131-135, including the 
exchange of Gly131 and Gly132 to Lys131 and Thr132, had a positive effect on helix 
recognition
helix
active site
motive
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propensity and improved the overall protein stability. The shortened hydrogen bonds 
measured in the SNAP-tag crystal structures are further evidence for a local 
stabilization of the alpha-helical fold (refer to table of H-bond length). Additionally, 
there is evidence that the alpha helix 127-136 of hAGT loses its structure upon 
alkyltransfer, which is due to an increase in sterical restrain. Mutations introduced in 
SNAP-tag stabilize the alpha helix and influence the stability of the whole protein, 
even or especially after alkylation. Overall, our studies show that Gly131 and Gly132 
are important residues that play a dual role in AGTs: accommodation of the substrate 
and contribution to unfolding and degradation of AGT upon alkyl transfer. 
Previous studies on the improvements of thermal stability showed that random 
mutagenesis of structural parts with high flexibility (as protein loops) is a promising 
strategy to improve protein stability. In order to identify these regions, B-factor 
analysis of X-ray crystallographic structures has successfully been applied173. Further 
it was shown that mutations, which “fix” regions, can have a strongly positive effect 
on protein stability and were principally localized on the surface of the protein 1. 
Despite the fact that our engineering efforts were not aiming at improvements in 
protein stability, we find the same mutation principles in SNAP-tag. Besides an 
increased reactivity, protein stability was improved by mutations in the region 150-
154, which created a hydrogen-bonding network on the surface of the protein. The 
mutations were introduced in the last round of directed evolution from MAGT to 
SNAP-tag. The importance of these residues for protein stability was confirmed by 
measurements of melting point temperatures in vitro as well as by pulse-chase 
experiments in cell culture. The results of these experiments confirmed an increased 
stability of SNAP-tag as well as its alkylated form. Crystal structure analysis and our 
computational data show a major contribution from the mutations Asn150Gln, 
Asn152Asp and Ala154Asp. The stabilizing effect of these interactions manifest itself 
also in lower B-factors in the SNAP-tag crystal compared to hAGT.  
Even though selection was focusing on reactivity, the stability of the generated 
mutants improved over the selection rounds. Especially in the last round of protein 
evolution (MAGT to SNAP-tag) the introduced mutations had a strong impact on both 
parameters. We believe that in the special case of alkyltransferases, the reason for the 
identification of more reactive mutants is due to the fact that the introduced mutations 
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structural motive (alpha helix-loop architecture) is also found in other 
alkyltransferases in various organisms. Additional work is currently undertaken to 
further characterize these interactions in the context of the onset of protein 
denaturation and helix stability. 
4.2 Generation of novel protein binders based on the SNAP-tag scaffold 
The second part of this thesis was aiming for the generation of a new SNAP-tag-based 
inhibitor complex against the two target proteins, eDHFR and Plk4. It was envisaged 
that this complex would interact with the target protein via amino acid loops and 
decrease its function only upon labeling with BG-inhibitor molecules. SNAP-tag was 
used as a scaffold into which randomized loop sequence were introduced at three 
different positions (residues 159/160 for library 1, residues 32/33 for library 2 and C-
terminal for library 3). The utilization of two yeast-based systems, the yeast three-
hybrid and two hybrid technologies, allowed for the differentiation of small-molecule 
dependent and independent binding interactions. It could be demonstrated that a 
specific protein-loop interaction could be generated by this approach. It could further 
be shown that inhibition of the catalytic activity of the target protein E.coli 
dihydrofolate reductase by a SNAP-loop mutant was possible. However, the 
identification of a small-molecule dependent interaction by Y3H has not been 
successful.  
4.2.1 Lessons from library design: 
Library design is one of the most critical steps in protein engineering. SNAP-tag loop-
libraries were based on a previously applied protein design154. Based on insights from 
this work we decided to add a stretch of random amino acids, either at position 32/33 
or position 159/160 of SNAP-tag.  
The analysis of Loop1 and the mutants obtained from the Plk4 screening revealed that 
the modification at position 159/160 strongly reduced protein reactivity.  
The reaction speed of Loop1 with BG-fluorescein was 28-fold lower than for SNAP-
tag and labeling with substrates carrying PEG-units or other linker-moieties was not 
successful. For SNAP-tag it was known that the reactivity with BG-substrates having 
a linker-unit was reduced compared to the reactivity with BG-fluorescein or BG-
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TMR. In these molecules a hydrophobic aromatic residue and a xanthene-moiety are 
directly attached to BG. A possible explanation for the good reactivity with these 
molecules is the way the directed evolution of SNAP-tag has been performed.  
During the directed evolution of SNAP-tag BG-fluorescein or structurally very 
similar molecules have been used in combination with fluorophore-specific antibodies 
to isolate the most reactive mutants. As evolution favored this kind of molecules over 
other structures they represent the best substrates. As a consequence molecules that 
carry a linker-unit are less reactive. In the case of the loop-mutants the reduction in 
reactivity was that strong that over-night incubation with BG-molecules containing a 
linker-moiety did not yield a detectable amount of labeled protein.  
For a better visualization of the loop positioning a computational model of Loop1 has 
been created (Figure 47 on the left). This model shows that the loop-part occupies the 
space that is in direct proximity to the active site. In hAGT this region is representing 
a part of the alkylguanine-binding channel. Our studies on hAGT and the intermediate 
mutants in the first part of this work showed that mutations in this part of the protein 
have an influence on protein reactivity, as mutations at position 157/159 in GEAGT 
improved reactivity because of the creation of new interactions with the substrate.  
Compared to this, the loop insertion at position 32/33 in library 2 is much less 
affecting the active site and therefore protein reactivity. A model for position 32/33 is 
shown in Figure 47 on the right, which confirms that the active site is unoccupied by 
this loop modification. The results of the labeling experiment (see also chapter 3.6.1) 
are in agreement to this hypothesis, as they showed that mutants from library 2 
reacted with all tested BG-substrates, even if they contained linker-units such as PEG.  
However, SNAP-mutants from library 2 were less frequently identified as protein-
binders than mutants from library 1. The loop sequences in library 1 might generally 
be presented in a better way for protein binding or the position of loop-insertion in 
this library is leading to a more structured loop, which would improve target protein 
binding. 
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Figure 47: Model of loop insertion in SNAP-tag for library 1 (position 159/160) and library 2 (position 32/33). 
The grafted peptide sequence (purple carbon atoms) is taken from Loop1 (RIKARTV) in both cases. The loop in 
library 1 occupies more space close to the active site cysteine (green carbon atoms), whereas the peptide insertion 
in library 2 seems to leave the active site unchanged. An impact on BG-reactivity for library 1 might be explained 
by this sterical influence.  
4.2.2 Conclusions and outlook: 
The aim of SNAP-tag engineering was the generation of a protein-binder that would 
inhibit the target protein function. We envisioned that inhibition would depend on the 
labeling with a BG-small molecule and considered three different approaches, all 
based on loop-mutant binding. First, the labeling with a BG-inhibitor molecule would 
directly target the active site of the protein leading to inhibition. Second, the labeling 
with a BG-photosentitizers for Chromophor-Assisted-Light-Inactivation (CALI) 
would release upon radiation Reactive Oxygen Species (ROS) in close proximity to 
the target protein, leading to the disruption of protein function174. The use of a self-
labeling protein-tag for CALI-applications has been reported recently175. The protein 
of interest was fused to the self-labeling protein-tag HaloTag and labeling with a 
suitable compound resulted in the depletion of protein function. Compared to this 
approach the binding of a reactive SNAP-mutant would have the advantage to target 
the native protein.  
The third approach would allow the monitoring of the protein-binding event using 
fluorogenic substrates linked to BG. Changes in fluorescence signal would represent 
changes in the protein conformation due to protein binding. Such a biosensor would 
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allow to monitor the protein dynamics inside living cells and would give precise 
information about the spatiotemporal dynamics of the target protein. A prerequisite 
for such an approach is that the binding event depends on the activity state of the 
target protein. A similar approach has been used by Nalbant et al. to monitor the 
timing and localization of active Cdc42, a small GTPase of the Rho-subfamily176. 
However, the isolation of a loop mutant with good reactivity towards BG-molecules is 
a perquisite and further work is needed to isolate mutants with good reactivity. 
The use of the Y3H technique was not successful in the identification of small-
molecule dependent interactions. However the Y2H screening identified protein-
binders whose interaction could be confirmed in vitro. The library that gave the best 
hit (library 1) carried the loop modification at a position that rendered the protein 
(partially) inactive, as no labeling with BG-inhibitor derivatives could be achieved.  
The decreased reactivity strongly limited the usefulness of the isolated mutants and 
was the main reason to not further pursue the experiments with the hits of loop library 
1 obtained in the Plk4-screening. However, these sequences should be analyzed for 
phosphorylation by Plk4 to see if the screening identified substrate peptides.  
For further protein engineering the positioning of the loop and its impact on reactivity 
have to be optimized. For the successful generation of a small-molecule dependent 
inhibitor of protein function it is important to choose a loop position that is in 
proximity to the active site and additionally does not have a negative impact on 
reactivity. As we have seen that the modification at position 32/33 was well accepted 
by the protein, one could envision the generation of a protein library carrying longer 
loop-sequences at this position to improve surface exposition and binding abilities. 
Alternatively, one could try to elongate SNAP-tag N-terminal to the recognition helix, 
between residues 125/126. From our experience on SNAP-tag engineering we know 
that point mutations in this region are accepted. Further, the positioning should ensure 
a good loop exposure on the protein surface and the substrate entry side should be less 
occupied than for library 1.  
Strength of the Y2H-technology is that weak interactions or complexes with low 
on/off-rates can be detected. This is extremely important for the identification of 
biological interactions as for example during the analysis of whole proteomes. In the 
case of our experiment, a more direct control over the binding conditions could have 
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facilitated the isolation of SNAP-mutants that react with BG-inhibitor molecules and 
at the same time bind to the protein of interest. To improve the screening output the 
focus needs to be put on methods that allow the isolation of mutants that either show 
different binding affinities dependent on protein labeling, or that react well with 
diverse BG-derivatives to bring the labels close to the target protein. The latter would 
be important for approaches as CALI or the use of fluorogenic probes as their 
working principle relies on the close proximity to the target protein. Selections based 
on protein display, on phage or bacteria, could represent an interesting alternative to 
the Y2H screening, as libraries could be screened for reactivity by Fluorescence 
Activated Cell Sorting (FACS) prior, or in combination with binding affinity 
screening 
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5 Materials and Methods 
5.1 Structural analysis of hAGT and mutants: 
SNAP-tag, hAGT and SNAP-mutant expression and purification. hAGT, SNAP-
tag and all mutants were cloned into pRSET vector (kind gift of Prof. Dr. Michael 
Groll) carrying an N-terminal hexa-histidine-tag (his6-tag) followed by a Prescission 
protease cleavage site. The plasmids were transformed into E.coli BL21 DE3 and 
directly used to inoculate a 20 mL pre-culture in LB containing 100μg/mL ampicillin. 
The pre-culture was diluted 50-fold and cells were grown at 37°C until an OD of 0.6-
0.8. At this cell density protein expression was induced by the addition of 0.5 mM 
isopropyl ß-D-1-thiogalactopyranoside (IPTG). After 16h at 18°C the cultures were 
harvested, the pellets were taken up in PBS supplemented with protease inhibitor 
cocktail (Roche) and lysed by sonication. The soluble fraction was used for Ni-NTA 
purification according to the manufacturers protocol (Qiagen). Protein was eluted in 
50 mM K2HPO4, 150 mM imidazol, 10% glycerol, pH 8.0. The eluted protein was 
incubated over night with Prescission protease and 10 mM DTT at 4°C. Subsequently, 
it was subjected to a ResQ 6 mL column (GE Healthcare) using buffer A (20 mM 
TRIS, 4 mM DTT, pH 8.0) and buffer B (20 mM TRIS, 4 mM DTT, 1 M NaCl, pH 
8.0). The corresponding elution fractions were pooled and concentrated. Homogenous 
protein was obtained by size exclusion chromatography (Superdex 200 column, GE 
Healthcare) using a buffer containing 20 mM TRIS, 4 mM DTT, 200 mM NaCl, pH 
8.0. The main fractions of the elution peak were pooled and concentrated to 5-8 
mg/mL. One aliquot of protein was directly used to assess protein stability by thermal 
denaturation. The other aliquots were supplemented with 30% glycerol and stored at  
-20°C until further use.  
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Trypsination. Protein solutions of hAGT, SNAP-tag and mutants were diluted to 1 
mg/mL in reaction buffer (20 mM TRIS, 4 mM DTT, 200 mM NaCl, pH 8.0) and 
separated in two aliquots. One aliquot of each protein was incubated with a 2-fold 
molar excess of BG-fluorescein for 1h at room-temperature, to the second aliquot the 
corresponding amount of DMSO was added. To check if the labelling reaction was 
completed a small aliquot was taken and quenched with 40-fold excess of BG-Cy5. 
Samples were analysed on SDS-PAGE to confirm complete labelling of the proteins 
prior to trypsination. Per sample 50 μL (50 μg) protein were mixed with 50 μL of 
different trypsin dilutions (trypsin stock were 1.0 mg/mL (1:1), 100 μg/mL (1:10), 10 
μg/mL (1:100), 1.0 μg/mL (1:1000), 0.1 μg/mL (1:10000) and 0 μg/mL). Samples 
were incubated for 1h at room temperature and quenched by the addition of 6x SDS-
sample buffer and heating for 3 minutes at 95°C. Samples were analysed by SDS-
PAGE followed by fluorescence-in-gel scanning on a Pharos FX Molecular Imager 
(Bio-Rad) and subsequent coomassie staining. 
 
Thermal denaturation assay. Proteins were diluted to 25 μM stock solutions in 
reaction buffer (20 mM TRIS, 4 mM DTT, 200 mM NaCl, pH 8.0) and ether pre-
incubated with 2 equivalents of BG or the corresponding amount of DMSO for 1 
hour. A small aliquot was taken and quenched with 30-fold excess of BG-fluorescein. 
The samples were analyzed by SDS-PAGE to ensure complete labelling prior to the 
experiment. 10 μL of the stock solutions were mixed with 10 μL of 30x SyproOrange 
(Invitrogen). The measurements were performed in MicroAmp Fast 96-Well Reaction 
Plates (Applied Biosystems) on a 7900 HT Real Time PCR System (Applied 
Biosystems). Heating ranged from 20-95°C at a ramping rate of 1%. Changes in 
fluorescence were monitored for all wells simultaneously using a charge-coupled 
device (CDD) camera. Dissociation curves were analyzed by plotting the first 
derivative of the curves (slope) against the temperature (dF/dT°) averaged over 4°C 
increments. The maximal value gave the melting temperatures (TM) of the proteins.  
 
Pulse-chase experiment. All constructs were cloned into pECFP-Nuc plasmid for 
mammalian cell expression using NheI/BamHI restriction sites. HEK 293 cells were 
cultured in EX-CELL 293 medium (Sigma) and transfected with the corresponding 
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plasmids using polyethylenimine (PEI). For this, cells were transferred to fresh HEK 
293 medium one day prior to the transformation at a cell density of 1.5x106 cells/mL. 
The day of the transfection cells were pelleted by centrifugation at 800 rpm for 5 
minutes and resuspended in RPMI1640 + GlutaMAX (GIBCO)+ 0.1% Pluoronic F68 
solution (Sigma) at a density of 2x107 cells/mL. 12.5 μg plasmid per millilitre cells 
were added plus 75 μL of 1ug/uL PEI. Cells were incubated at 37°C under shaking 
(200 rpm). After 2 hours cultures were diluted 20-fold in fresh HEK 293 medium. 
Cells were cultured for 24 hours prior to the experiment. Cells were labelled for 15 
min with 0.65 μM CP-TMR-star (Covalys) and blocked with 500 μM BG. Extensive 
washing with 500 μM BG-containing media for 30 minutes and 100 μM BG-
containing media for 3 hours blocked labelling and removed non-reacted dye 
sufficiently. Samples were taken at different time points for protein extraction and 
SDS-PAGE analysis followed by fluorescence-in-gel scanning (Pharos FX Molecular 
Imager, Bio-Rad).  
 
Molecular Dynamics calculations. Computational models of SNAP-tag and wild-
type hAGT were constructed, starting from crystallographic non-benzylated (pdb 
entries 3KZY and 1EH6, respectively) and benzylated structures (pdb entries 3L00 
and 1EH8, respectively) in which the unresolved loop region (residues 36 to 44 in 
hAGT and residues 36 to 49 in SNAP-tag) was added manually. AMBER parm99SB 
charges and atom types were used to build the topologies for each of the structures 
with zinc parameters, where distance restraints were used for the coordination of the 
zinc ion to the cysteine residues in the N-terminal domain. The structures were 
solvated in a periodically repeated TIP3P water box with dimensions 81 X 80 X 70 Å3 
(corresponding to a 15 Å solvation shell around the protein). All structures were 
minimized, heated to 300K under constant volume conditions with 5.0 kcal mol-1 
positional restraints on the protein (except the unresolved loop), followed by 
equilibration under constant temperature and pressure conditions, slowly releasing the 
restraints over 4 ns. Data were collected from production phase simulations, in which 
Molecular Dynamics (MD) trajectories were run for 30-50 ns using the Particle Mesh 
Ewald (PME) MD module in AMBER v10. During the simulations, the PME method 
was used with a cut off of 8.0 Å for non-bonding interactions. Constant pressure 
periodic boundaries conditions were maintained with a pressure relaxation time of 2 
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ps. The SHAKE algorithm was used to constrain all bonds that involve hydrogen 
atoms. The Langevin method for temperature control was used with a collision 
frequency of 1 ps-1. 
Free energy perturbation methods, in combination with thermodynamic integration 
(FEP/TI), were used within the Simulated Annealing with NMR-derived Energy 
Restraints (SANDER) module of AMBER v10. Using a dual topology paradigm, two 
topologies (state 0 and state 1) for each transformation were constructed by manually 
imposing point mutations on the equilibrated MD structures of the free enzymes, 
SNAP-tag and hAGT. The electrostatic and Lennard Jones terms were decoupled by 
performing three separate alchemical transformations: (i) decharging state 0 using 30-
40 lambda points (ii) transforming the atoms of state 0 into those of state 1 using 20 
lambda points and (iii) recharging state 1 using 30-40 lambda points. Convergence 
was tested for by extending the duration of the MD run and by increasing the number 
of lambda points. In each transformation, all lambda points were individually 
minimized, equilibrated, and data were collected during a production phase of 1 ns. 
The change in the potential energy as a result of the perturbation was integrated over 
the lambda values to obtain the ΔG for each mutation. A per residue decomposition 
for the charging and de-charging steps was performed to indicate the primary points 
in the protein that are affected by the mutation. 
 
 
5.2 Engineering of SNAP loop-mutants: 
Standard reagents. The standard protocols in yeast biology were taken from the 
textbook “Short protocols in molecular Biology177”. If not specified elsewhere, the 
same source was used for the preparation of standard reagents for molecular biology 
experiments.  
 
Yeast strain. The reporter yeast strain NMY51C3 was derived from NMY51 
(Dualsystems Biotech, Switzerland) by gene disruption of PDR5 and SNQ2, two 
genes coding for a multi-drug resistance transporter for better uptake of small 
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molecule compounds. NMY51C3 genotype: MATa his3-Δ200 trp1-901 leu2-3,112 
LYS2::(lexAop)4-HIS3 ura3::(lexAop)8-lacZ (lexAop)8-ADE2 GAL4 Δpdr5::loxP 
Δsnq2::loxP. Reporter genes includes two auxotrophic (HIS3 and ADE2) and one 
colorimetric (lacZ). 
5.2.1 Library construction and screening set-up: 
SNAP-tag libraries. SNAP-tag loop libraries were produced by PCR using 
degenerated primers. Loop insertion at amino acid position 159/160 (library 1) of 
SNAP-tag was realized with the following scheme: A first PCR reaction was 
performed using BM01/BM04, a second, separate PCR reaction with BM02/BM03. 
After purification of the PCR products by gel-extraction an assembly-PCR of the two 
PCR-products that had partially overlapping fragments was performed using primers 
BM03/BM04. For loop insertion at amino acid position 32/33 (library 2) of SNAP-tag 
the same scheme was used with different primers pairs for the first (BM04/BM05) 
and second (BM03/BM06) PCR-reaction. Assembly-PCR was performed using the 
same primers as above (BM03/BM04). The full-length products were digested with 
restriction endonuclease SfiI for 5h at 50 °C, purified by gel-extraction and ligated 
into pGAD-HA following an optimized protocol using three equivalents of insert to 
one equivalent linearized vector (1μg vector per ligation reaction) at 21°C for 4h. 
Large-scale transformation of 10 μg library DNA into XL1-blue was performed by 
stepwise electroporation of 0.5 μg DNA per 100μl cells. Transformation mixes were 
pooled, incubated at 37°C for 1 hour and plated on twenty 15 cm agar plates. After 
incubation ON 5 mL LB medium, 25% glycerol were added on each plate, the cells 
were scraped off and collected in an 50 mL Erlenmeyer. Transformation efficiency 
was determined for each library and was determined to be 3*106 colonies per μg DNA 
for library 1 and 2.2x106 colonies per μg DNA for library 2 and a total complexity of 
3x107 different clones for library 1 and 2.2x107 different clones for library 2. Cells 
were aliquoted and stored at -80°C for subsequent large scale DNA preparation 
(MaxiPrep, Qiagen) according to the manufacturers protocol.  
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Bait vectors. Constructs for eDHFR, eDHFR mutant 1, eDHFR mutant 2 and eDHFR 
mutant 3 expression in yeast were amplified by PCR using the primer pair BM09/10 
and cloned into the vector pLexA using the SacI/SalI restriction sites. The mutants 
differ in the following point mutations from wild-type eDHFR: mutant 1 has point 
mutation of L54I, mutant 2 carries the mutation L54G and mutant 3 has the mutations 
of L54G plus F31V. All those mutations influence the binding affinities to the 
substrate and NADPH. Constructs of Plk4 full length (Plk4-fl), a short version of the 
kinase domain (Plk4-KD-short, 795 bp) and a longer version of the kinase domain 
(Plk4-KD-long, 1170 bp) were cloned into pLexA-N vector using the primers 
BM11/BM12 for full length construct, BM11/BM13 for the short fragment of the 
kinase domain and BM11/BM14 for the long kinase fragment and SacI/SalI 
restriction sites.  
 
Bait expression control in yeast. After transformation of the corresponding plasmids 
and two control plasmids (empty pLexA, pLexAp53) into the reporter yeast strain 
NMY51C3 the cells were streaked out on CM–W agar plates and incubated at 30°C 
for 2 days. A single colony of the strain was re-suspended in CM-W liquid medium 
and grown overnight at 30°C and intensive shaking. The next morning, the cultures 
were diluted to an OD600 of 0.4 and was shaken at 30°C for an extra 5-6 hours. The 
optical density OD600 of the culture was determined and the equivalent of 1 mL of an 
OD600=1 culture (= 1 OD600) was pelleted in a 1.5 mL tube. The cell pellets were 
washed in 1mL water, resuspended in 50 μL ice-cold 1.85 M NaOH supplemented 
with 7.4 % beta-mercaptoethanol. After incubation on ice for 10 minutes 50 μl of 50% 
trichloroacetic acid were added to each tube and incubated again for 10 minutes on 
ice. Samples were centrifuged at maximal speed for 2 minutes, the supernatant was 
discarded and the pellets resuspended in 10 μL of 1M Tris base. 40 μL of 2x SDS-
sample buffer were added and samples were boiled at 95°C for 5 minutes. After 
centrifugation at maximal speed for 2 minutes 20 μL of the supernatant were loaded 
on a 15% SDS-PAGE gel.  
The proteins were then transferred onto a PVDF membrane (Immobilion-P, Millipore) 
using a semi-dry transfer system according to the membrane manufacturer’s 
instructions (Millipore Immobilon-P transfer membrane user guide). After transfer, 
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the membrane was blocked for 1h in TBST (20 mM Tris-HCl, 500 mM NaCl, 0.005% 
v/v Tween-20, pH 7.5) + 5% skim milk powder. After washing 2 times with TBST for 
5 minutes, the membrane was incubated with anti-LexA mouse antibody (stock at 200 
μg/μL, Dualsystems Biotech) diluted 1:5000 in TBST + 5% skim milk powder for 45 
minutes at room temperature then for 11h at 4°C. After washing 2 times with TBST, 
the membrane was incubated with an anti-mouse antibody-HRP conjugate (A4416, 
Sigma) diluted 1:2000 in TBST + 5% skim milk powder for 1.25 h at RT. The 
detection of the immunoblot was performed using ECL Plus Western Blotting 
Detection Reagents (GE Healthcare) and a Kodak Image Station 440CF. The 
quantification of the chemi-luminescence signal was performed using the Kodak 1D 
software.  
 
Quantification of labeling efficiency of SNAP-tag with BG-derivatives in yeast 
cells. Yeast cells were transformed with the plasmid pLexA-CLIP-SNAP and grown 
in CM-WL medium. Transformed yeast cells were grown to an OD600 of 0.8-2.0. For 
liquid labeling 1x108 cells were harvested by centrifugation at 1,500x g for 5 minutes 
and then washed in 1 volume PBS pH 6.5. The cell pellets were next re-suspended in 
100 μL PBS and BG-derivatives were added to a final concentration of 10 and 50 μM. 
In order to quantify the full BG-Cy5 labeling, a control sample was included in which 
no BG-derivative was added (DMSO only). The suspension was then shaken in a 
benchtop thermomixer (Eppendorf) at 1,200 rpm at 30°C for 3 hours. The cells were 
harvested, washed in PBS and taken up in 120 μL labeling mix (50 mM HEPES pH 
7.2, 1mM DTT, 2.5 μM BG-Cy5 and 2.5 μM BC-Cy3 (Covalys). A volume of 200 μL 
of acid-washed glass beads(Sigma) was added to the suspension and yeast cells were 
disrupted by full-speed vortexing for 5 x 1 minute with 1 minute incubation on ice 
between each cycle. The disrupted cells were incubated for 30 minutes at RT for 
quantitative labeling of SNAP-tag and CLIP-tag. After centrifugation at 16,000x g for 
5 minutes, 50 μL of the supernatant were added to 10 μL 6x SDS sample buffer. After 
boiling at 95°C for 5 minutes the samples were loaded on a 15% SDS-PAGE gel.  
NMY51 C3 cells expressing the ACT-AGT fusion protein were grown in liquid 
medium (CM-WL) ON and plated out on 1% agarose plates containing different BG-
derivatives in 10 μM concentration to compare labeling efficiency in liquid medium 
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and on agar plates. As a control, a plate not containing any BG-derivative (DMSO 
only) was included. Cells were incubated for 4 days at 30°C, resuspended in 1-2 mL 
PBS and 1x108 cells per sample were washed and resuspended in 50 mM HEPES pH 
7.2, 1 mM DTT. Cells were lysed by glass-beads in the presence of 200 μM BG-Cy5 
and BC-Cy3 (Covalys). After centrifugation at 16,000x g for 5 minutes, 50 μL of the 
supernatant were added to 10 μL 6xSDS sample buffer. After boiling at 95°C for 5 
minutes the samples were loaded on a 15% SDS-PAGE gel. 
In-gel fluorescence scanning of dyes BC-Cy3 and BG-Cy5 was performed on a 
PharosFX Molecular Imager (BioRad) and intensities of fluorescence were quantified 
using Quantity One software (BioRad). The labeling efficiency of SNAP-tag with the 
different BG-derivatives in living yeast cells was then calculated based on the signal 
intensity of the control labeling samples (DMSO only), which was set to 100% of 
labeling.  
 
Optimization of screening conditions. The screening conditions were optimized 
according to the different levels of auto-activation of the different baits proteins. The 
yeast reporter strain was transformed with pLexA-N-bait constructs together with 
pGAD-HA-SNAP and plated on selective (CM-HWL) and non-selective (CM-WL) 
agar plates. After 5 days of incubation at 30°C the plates were analysed. Additionally, 
large-scale transformations according to the final screening conditions were 
performed following the protocol of Gietz et al178. As screening conditions 2.5 mM 3-
aminotriazole were chosen to suppress any unspecific reporter gene activation due to 
the bait-proteins and quantity of yeast cells plated on screening plates. 
 
High efficiency transformation of yeast with SNAP-tag loop libraries.  The yeast 
strain NMY51C3 was pre-transformed with the SNAP-tag bait plasmid (pLexA-
SNAP) according to standard procedures. The bait expressing yeast strain was then 
transformed with the SNAP-tag libraries achieving at least 1x106 transformants per 
library. All three libraries were transformed using a high efficiency protocol from 
R.D. Giezt et al178. Transformations using the 10x TRAFO scale were performed each 
with 5 μg plasmid DNA. The TRAFO protocol was followed except for the heat 
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shock time which was increased to 40 minutes at 42°C. The transformed cells were 
homogenously spread (4 mm diameter glass beads) on 5 to 10 large 150 mm Petri 
dishes containing CM-WL growth medium. The transformation efficiency for each 
library was determined by plating dilutions of the transformed cells onto CM-WL 
agar plates. After 2-3 days at 30°C, the yeast cells were re-suspended in 1xTE and 
pooled. The pooled yeast cells were washed twice with 1 pellet volume 1xTE and re-
suspended in 1 pellet volume freezing solution (65% glycerol, 100 mM MgSO4, 25 
mM Tris-HCl pH 8.0). The 50% slurry was aliquoted and stored at -80°C. All 
manipulations with yeast cells from the beginning of the transformation procedure to 
the preparation of aliquots of the transformed yeast cells were performed under sterile 
conditions in a laminar flow hood.  
 
5.2.2 Yeast screening: 
Yeast growth media. Standard media was prepared as described in “Short Protocols 
in Molecular Biology177”. The preparation of specific growth media for Y3H 
applications is described hereunder. All media were supplemented with 0.1 g/l 
adenine (NMY51-type yeast are ade2 mutant). 
 
Preparation of non-selective growth medium (CM -LW). Non-selective medium 
for Y3H was composed of 1.4 g/l dropout mix -HLWU (Sigma), 0.1 g/l uracil, 0.05 
g/l histidine, 0.1 g/l adenine, 1.7 g/l yeast nitrogen base, 5 g/l ammonium sulphate, 20 
g/l D-glucose (added after autoclaving), 15 g/l agar and adjusted to pH 5.6 with 
NaOH. 
 
Preparation of selective growth medium (CM -HLW). Selective medium for Y3H 
was composed of 1.4 g/l dropout mix -HLWU (Sigma), 0.1 g/l uracil, 0.1 g/l adenine, 
1.7 g/l yeast nitrogen base, 5 g/l ammonium sulphate, 20 g/l D-glucose (added after 
autoclaving), 15 g/l agar and adjusted to pH 5.6 with NaOH.  
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Preparation of selective growth medium for Y3H positive selection (CM -HLW + 
2.5 mM 3-AT + 10 μM BG derivative). Selective medium for Y3H was composed 
of 1.4 g/l dropout mix -HLWU (Sigma), 0.1 g/l uracil, 0.1 g/l adenine, 1.7 g/l yeast 
nitrogen base, 5 g/l ammonium sulphate, 20 g/l D-glucose (added after autoclaving), 
10 g/l agarose and adjusted to pH 6.5 with NaOH. Furthermore, the medium was 
adjusted after autoclaving (T <50 °C) to 2.5 mM 3-AT from a 1 M stock in H2O and 
to 10 μM BG drug derivative from a 10-20 mM stock in DMSO. 
Y2H and Y3H selection of affinity mutants. Each selection (1 library versus one 
bait protein) was performed on 1 large petri dish (150 mm diameter) containing CM-
HWL + 2.5 mM 3-amino-1,2,4-triazole (3-AT) + 1% agarose, pH 6.5. The screening 
was performed as Y2H screening without the incorporation of a BG-small molecule 
and as Y3H screening in which the agar plates were supplemented with 10 μM of BG-
small molecule. Yeast cell stocks containing the corresponding bait protein together 
with one library were thawed and approximately 1x107 colony forming units (cfu) 
were diluted in 1xTE buffer and homogeneously spread (4 mm diameter glass beads) 
on the selection plates. After 5-7 days at 30°C, all colonies larger than 1 mm in 
diameter were picked using plastic disposable 200 μL pipette tips and resuspended in 
100 μL 1xTE in 96-well plates. Using a multi-channel pipette the re-suspended 
colonies were transferred onto large non-selective agar plates (CM-WL). After 3 to 4 
days at 30°C, the arrayed colonies were transferred back to 100 μL 1xTE in 96-well 
plates and re-plated using a Singer RoToR HDA robot. The respotting on selective 
(CM-HWL) media with our without BG-small molecule derivative (10 μM) assessed 
the small molecule dependency of the interaction.  
 
Identification of screening hits. All yeast spots showing growth after re-spotting 
were picked from the corresponding non-selective plates by manual colony picking 
using disposable 200 μL pipette tips and re-suspended in 100 μL 1xTE in 96-well 
plates. Using the RoToR HDA robot the re-suspended colonies were transferred onto 
CM-HWL agar plates containing increasing amounts of 3-AT (0 μM, 1 μM, 2.5 μM, 5 
μM and 10 μM). After 4 days of growth at 30°C the colonies were selected according 
to their resistance towards 3-AT. Colonies growing at 2.5 μM or higher 3-AT 
concentrations were considered as putative hits and inoculated in 1.5 mL CM-WL 
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liquid medium in 96-well deep well plates. After growing until saturation, the cultures 
were used for plasmid DNA-preparation. Yeast cells were centrifuged at 1,000x g for 
10 minutes, the pellets resuspended in 200 μL zymolyase solution (1.2 M sorbitol, 
100 mM sodium phosphate pH 7.4, zymolyase 20T 2 mg/mL (Seikagaku 
Biobuisiness) and incubated at 37°C for 90 minutes with shaking. The plasmid DNA 
was then isolated by MiniPrep (Quiagen) or by using a DNA isolation kit in 96-well 
format (NucleoSpin M-96 Plus Plasmid, Macherey-Nagel). The instructions from the 
manufacturer were followed starting from the addition of the alkaline lysis solution to 
the yeast suspension pre-treated with zymolyase. The isolated plasmids were 
transformed in chemical competent E.coli XL1-blue cells to increase the plasmid 
yield and to ensure, that only one plasmid per colony is propagated. The plasmids 
were again isolated using a DNA-isolation kit (Qiagen or Macherey-Nagel) and 
sequenced.  
 
Confirmation of the yeast hits. A confirmation of the Y2H interaction using 
retransformed yeast strains was performed for all sequenced plasmids coding for a 
mutant of SNAP-tag. Plasmids were transformed into yeast already carrying the 
corresponding pLexA-bait plasmid using a standard yeast transformation protocol. A 
single yeast colony for each transformed yeast strain was diluted into 100 μL 1x TE in 
96-well plates. The yeast suspensions were serially diluted 10-fold 4 times. 2 μL of 
the suspensions and dilutions were spotted each on CM-WL, CM-HWL and CM-
HWL + 2.5 mM 3-AT agar plates using a RoToR HDA robot. The plates were 
incubated at 30°C for 3-5 days prior to growth analysis. Yeast colonies that grew on 
selective plates were considered as reconfirmed potential hits in yeast and submitted 
to further testing.  
Bait dependency test of potential hits in yeast. The specificity of Y2H interactions 
was tested by transformation of different pLexA-bait plasmids in yeast that was 
already expressing one pGal4-SNAP-mutant at a time. The transformations were 
performed according to standard protocol. A single yeast colony for each transformed 
yeast strain was diluted into 100 μL 1x TE in 96-well plates. The yeast suspensions 
were serially diluted (10-fold). 2 μL of the suspensions and dilutions were spotted 
each on CM-WL, CM-HWL and CM-HWL + 2.5 mM 3-AT agar plates using a 
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RoToR HDA robot or manually. The plates were incubated at 30°C for 3-5 days prior 
to growth analysis. Yeast colonies that grew only in the presence of the right bait 
protein on selective plates were considered bait specific potential hits in yeast and 
submitted to further testing.  
 
5.2.3 Hit-validation: 
DHFR activity assay. eDHFR was expressed and purified from E.coli. The construct 
for N-terminal (his)6-tagged eDHFR was created by PCR using the primers 
BM17/BM18. The PCR product was ligated in pET-15b vector (Novagen) via BamHI 
sites. Activity of eDHFR was measured based on NADPH consumption causing a 
decrease of absorption at 340 nm. 5 nM eDHFR were added to a solution containing 
80 μM NADPH and 200 μM dihydrofolic acid (DFH2) (both Sigma) in reaction buffer 
(50 mM Tris-HCl pH 6.8, 0.01% Trition-X-100, 10 mM beta-mercaptoethanol, 0.5 
mg/mL BSA). The assay was performed in a 96-well micro test plates (Ratiolab) and 
measured on a micro plate spectrophotometer (SpectraMAX, Molecular Devices). For 
inhibition studies serial dilutions of control (SNAP-tag) and inhibitor (Loop1 mutant 
or Methotrexate) were pre-incubated with eDHFR for 30 minutes prior to the addition 
of NADPH and DFH2. Samples were measured every 15 seconds for 1 hour and 
evaluated by plotting the initial slopes against the corresponding inhibitor 
concentration.  
 
Cross-linking experiment. Proteins to be tested were expressed as SNAP-tag-fusion 
proteins either in E.coli cells or HEK293 cells and further purified via his-tag, GST-
tag or FLAG-tag according to the manufacturers protocols. Proteins were dialyzed in 
20 mM Tris, pH 6.8, 50 mM NaCl, 1 mM beta-mercaptoethanol supplemented with 
0.1% BSA. For the experiment 200 nM protein A were mixed with 200 nM protein B 
in dialysis buffer to a total volume of 100 μL and incubated for half an hour at room 
temperature. 1 μM of BG-TMR-BG cross-linker (LR 223) or CP-TMR-CP (LR222) 
were added and mixes were incubated for 1h at 37°C. 6x-SDS-sample buffer was 
added and reactions were heated for 3 minutes at 95°C. After cooling down of the 
samples, 30 μL were loaded on a 5-15% gradient Tris-buffered gel and SDS-PAGE 
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analysis was performed. Fluorescence intensities were recorded on a PharosFX 
Molecular Imager (BioRad) and bands confirmed by Western blotting against GST-, 
and his-tag following the manufacturers recommendations.  
 
Loop mutant labeling efficiency. The identified loop mutants from the Plk-4 
screening were analyzed for their labeling efficiency in E.coli BL21 DE3 cells. 
Expression vectors were prepared using Gateway recombination cloning (Invitrogen) 
with primer pair BM19/20, pDONR221 and destination vector pDEST15. Cells were 
lysed by sonication (2-times 5 minutes, 50 % duty, 80% power), supplemented with 
protease inhibitor cocktail (Roche) and incubated with 5 μM of BG-dye for 30 
minutes at room temperature. Three different BG-dyes were tested: BG-fluorescein 
(New England Biolabs), BG-PEG(4)-DAP(488)-COOH (Dr. Luc Raymond, Johnsson 
laboratory) and BG-PEG(7)-DAP(Rh110)-NH2 (Dr. Luc Raymond, Johnsson laboratory). 
50 μL of the lysate were mixed with 10 μL of 6x SDS-loading dye and samples were 
boiled for 3 minutes at 95°C. 15 μL of each sample were loaded on a 15% SDS-
PAGE gel and analyzed by in-gel fluorescence scanning on a PharosFX Molecular 
Imager (BioRad). 
 
GST-pulldown. GST-constructs of identified SNAP-mutants were made by cloning 
into pGex-2T vector using the primer pair BM07/BM15 for the loop motive 
RIKARTV and BM07/BM16 for the C-terminal SNAP-mutants (BamHI/EcoRI 
cloning sites). Proteins were expressed in E.coli BL21 DE3 cells using standard LB 
medium, induction at OD600= 0.6 with 0.5 mM IPTG and expression overnight at 
16°C. Cells were lysed and cleared by centrifugation at full speed for 30 minutes. The 
supernatent was collected and glycerol added to a final concentration of 15% (v/v). 
Lysate stocks were ether used directly or stored at -80°C. For the pulldown 
experiment 25 μL of 20% GST-sepharose beads slurry (GE Healthcare) were added to 
50 μL GST-SNAP or GST-mutant lysate and incubated under rotation for 30 minutes 
at 4°C. The beads were washed three times in pulldown buffer (50 mM Tris-HCl pH 
7.9, 150 mM NaCl, 1 mM DTT, 0.1 mg/mL BSA, 1 tablet inhibitor cocktail (Roche) 
for 10 mL buffer) and resuspended in pulldown buffer containing 10 μM BG-
methotrexate. Mix was incubated for 30 minutes at room temperature and washed 
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three times with buffer. Purified DHFR was added to a total amout of 5-10 μg of 
protein and incubated for 1 hour at 4°C. Beads were washed three times in buffer and 
protein eluted by the addition of glutathione elution buffer (50 mM Tris-HCl pH 7.9, 
10 mM reduced glutathione). Mix was incubated for 30 minutes at room temperature, 
15 μL supernatant collected and mixed with 15 μL 2x SDS-sample buffer. For 
analysis 20 μL of sample were loaded on a SDS-PAGE and ether stained by 
coomassie or protein was transferred to PVDF membrane (Immobilion-P, Millipore) 
for Western blot analysis.  
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5.3 List of Primers: 
BM01:CCAGGGGGATTTGGATGTGGGCGGTTACNNKNNKNNKNNKNNKNN
KNNKGGACTGGCCGTGAAGGAATG 
BM02:GTAACCGCCCACATCCAAATCCC 
BM03:ACCAATTGCCTCCTCTAA 
BM04:TGCACGATGCACAGTTGAAG 
BM05:GAGCAGGGTCTGCACGAAATANNKNNKNNKNNKNNKNNKNNKNN
KGGCAAGGGGACGTCTGCAGCTGAT 
BM06:TATTTCGTGCAGACCCTGCTC 
BM07:CGCGGATCCGACAAGGATTGTGAAATGAAACGC 
BM08:CGCGGATCCTTATGGCTTCCCCAACCGGTGGCC 
BM09:GACGAGCTCATGATCAGTCTGATTGCGG 
BM10:GAGTTGGTCGACTTACCGCCGCTCCAGAATC 
BM11:AGTAGAGCTCATGGCGACCTGCATCGG 
BM12:ATCTGTCGACTTACTATCAATGAAAATTAGGAGTCG 
BM13:ATCTGTCGACTTACTACATAAAAGGATGGTCCAATAC 
BM14:CGGCGTCGACTTACTATTGAGACTGTCTATTAGAAGTGCC 
BM15:GCGGAATTCTATGGCTTCCCCAACCGGTG 
BM16:GCGGAATTCCGATGCCCACCCTCTAGATC 
BM17:TCAGGATCCTATGATCAGTCTGATTGCGGC 
BM18:TCAGGATCCTTACCGCCGCTCCAGAATCT 
BM19:GGGGACAAGTTTGTACAAAAAAGCAGGCTCGGACAAGGATTGTGA
AATGAA 
BM20:GGGGACCACTTTGTACAAGAAAGCTGGGTCTTATCATCCCAAGCCT
GGCTTC 
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